Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Målrettet terapi rettet af genetisk testning i behandling af patienter med lokalt avancerede eller avancerede solide tumorer, ComboMATCH Registration Trial

11. november 2026 opdateret af: National Cancer Institute (NCI)

Molekylær analyse for valg af kombinationsterapi (ComboMATCH)

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.

Studieoversigt

Status

Rekruttering

Detaljeret beskrivelse

PRIMARY OBJECTIVE:

I. To register, allocate, and assign patients to ComboMATCH treatment trials.

SECONDARY OBJECTIVES:

I. To evaluate the rate of positive outcomes in defined cohorts within treatment trials of treatment combinations including targeted therapies for molecularly defined populations, and also in the subset of treatment trials where the treatments are supported by in vivo models.

II. To perform quality control of the patients registered in the form of pathological confirmation of disease and sub-type to confirm diagnosis and treatment arm allocation.

SECONDARY CORRELATIVE OBJECTIVES:

I. Assess the concordance of the central molecular characterization of the pre-treatment biopsy samples with the genetic readouts from the Designated Laboratories (DLs) for patients enrolled on the ComboMATCH treatment trials.

II. To assess how the registration diagnostic tumor mutation profile and pre-treatment biopsy profile compare to the circulating tumor-derived deoxyribonucleic acid (ctDNA) mutation profile from plasma.

EXPLORATORY OBJECTIVE:

I. Assess association between ComboMATCH treatment trials outcomes (positive or negative) with the type of rationale for the selected drug combinations and the type of rationale for the gene variant/combination for selection (e.g., whether the trial was based on targeted therapies for molecularly defined populations, those that were supported by in vivo models, and those that were supported by empiric clinical data).

OUTLINE:

REGISTRATION: Patients undergo tumor mutational screening of previously-collected tumor samples for specific, pre-defined mutations, amplifications, or translocations of interest via tumor sequencing. Patients who are 18 years or older and have biopsiable disease undergo a new biopsy for research purposes prior to initiating treatment on the ComboMATCH treatment trial.

TREATMENT: Patients with mutations targeted to investigational combination therapies are assigned to 1 of 20 treatment subprotocols.

EAY191-N4: Patients with RAS pathway mutant ovarian or endometrial cancer are randomized to 1 of 2 arms.

ARM I: Patients receive selumetinib orally (PO) twice daily (BID) and olaparib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo a tumor biopsy and blood collection during screening and on study, as well as echocardiogram (ECHO) or multigated acquisition (MUGA), and computed tomography (CT) scans throughout the trial. Patients may undergo bone marrow aspiration or biopsy as clinically indicated.

ARM II: Patients receive selumetinib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who experience progression may elect to cross over to Arm I provided they have not had dose limiting toxicities to monotherapy selumetinib. Patients also undergo a tumor biopsy and blood collection during screening and on study, as well as ECHO or MUGA, and CT scans throughout the trial. Patients may undergo bone marrow aspiration or biopsy as clinically indicated.

EAY191-N2: Patients with inactivating or inferred inactivating NF1 alterations, and hormone receptor positive, HER2-negative metastatic breast cancer. Patients who are fulvestrant naive are assigned to Cohort I, while patients who are fulvestrant resistant are assigned to Cohort II.

COHORT I: Patients are randomized to 1 of 2 arms.

ARM I:Patients receive fulvestrant intramuscularly (IM) on day 1 and day 15 of cycle 1 and day 1 of subsequent cycles and binimetinib PO BID on days 15 to 28 of cycle 1 and day 1 through 28 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo a CT, magnetic resonance imaging (MRI), or bone scan, ECHO or MUGA, and tumor biopsy, as well as possible blood sample collection during screening and on study.

ARM II: Patients receive fulvestrant IM on day 1 and day 15 of cycle 1 and day 1 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who progress on fulvestrant alone may migrate to cohort II if they meet the migration eligibility criteria. Patients not willing to migrate to cohort II will have further therapy at the investigator's discretion. Patients undergo a CT, MRI, or bone scan and tumor biopsy, as well as ECHO or MUGA and possible blood sample collection during screening and on study.

COHORT II: Patients receive fulvestrant IM on day 1 of each cycle and binimetinib PO BID on days 15-28 of cycle 1 and day 1 through 28 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo a CT, MRI, or bone scan, ECHO or MUGA and tumor biopsy, as well as possible blood sample collection during screening and on study.

EAY191-E4: Patients with solid tumors who previously underwent taxane therapy.

Patients receive nilotinib hydrochloride monohydrate PO BID on days 1-28 and paclitaxel intravenously (IV) over 1 hour on days 1, 8, and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo CT or MRI during screening or cycle 1 day 1, every 2 cycles for 1 year, every 3 cycles for patients on study for more than 1 year, and every 4 cycles for patients on study for more than 3 years and may also undergo CT or MRI during follow-up every 3 months for 2 years and then every 6 months for 1 year if clinically indicated. Patients also undergo collection of blood samples at baseline, cycle 2 day 1, and optionally at progression as well as tumor biopsy at baseline and optionally at progression.

EAY191-A3: Patients with KRAS/NRAS/BRAF mutated low-grade serous ovarian cancer (LGSOC) naive to MEK or CDK4/6 inhibitor therapy are randomized to either combination cohort 1 or monotherapy cohort 1. Patients with LGSOC who have received prior MEK inhibitor therapy are assigned to combination cohort 2. Patients with KRAS/NRAS/HRAS/non-V600E BRAF mutated pancreatic cancer are assigned to combination cohort 3. Patients with all other KRAS/NRAS/HRAS mutated tumor types (excluding LGSOC, non-small cell lung cancer, colorectal cancer, pancreatic, and melanoma) are assigned to combination cohort 4.

COMBINATION COHORTS 1, 2, 3, 4: Patients receive palbociclib PO and binimetinib PO throughout the trial. Patients may also undergo biopsy at screening and undergo MRI, CT, bone scan, and collection of blood samples during screening, on study, and/or during follow up.

MONOTHERAPY COHORT 1: Patients receive binimetinib PO throughout the trial. Patients may also undergo biopsy at screening and undergo MRI, CT, bone scan, and collection of blood samples during screening, on study, and/or during follow up.

EAY191-S3: Patients with an activating AKT mutation solid tumor.

Patients receive paclitaxel IV on days 1, 8, and 15 and ipatasertib PO on days 1-21 of each cycle. Treatment repeats every 28 days for up to 35 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo a CT or MRI and blood collection throughout the trial. Patients also undergo a tumor biopsy during screening and optionally during follow-up.

EAY191-A6: Patients with RAS/RAF/MEK/ERK mutant biliary tract cancers are randomized to 1 of 2 arms.

ARM 1: Patients receive leucovorin IV, oxaliplatin IV, and fluorouracil IV on study. Patients undergo echocardiogram (ECHO) and multigated acquisition scan (MUGA) during screening and on study, a CT with contrast, MRI, or a fludeoxyglucose F-18 positron emission tomography (FDG-PET) during screening, collection of blood during screening and on study, and a biopsy during screening. Patients may also undergo brain MRI or CT during screening and on study, bone scans on study, and biopsy on study if clinically indicated.

ARM 2: Patients receive binimetinib PO, leucovorin IV, oxaliplatin IV, and fluorouracil IV on study. Patients undergo ECHO and MUGA during screening and on study, a CT with contrast, MRI, or an FDG-PET during screening, collection of blood during screening and on study, and a biopsy during screening. Patients may also undergo brain MRI or CT during screening and on study, bone scans on study, and biopsy on study if clinically indicated.

EAY191-E5: Patients are assigned to 1 of 2 cohorts.

COHORT I: Patients who have never received a KRAS G12C inhibitor are randomized to arms A or B.

ARM A: Patients receive sotorasib PO once daily (QD) on days 1-28 and panitumumab intravenously IV on days 1 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo collection of blood samples, biopsy, and CT or MRI on study.

ARM B: Patients receive sotorasib PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients with disease progression may cross-over to cohort II. Patients also undergo collection of blood samples, biopsy, and CT or MRI on study.

COHORT II: Patients who have received a KRAS G12C inhibitor are assigned to arm C.

ARM C: Patients receive combination therapy as in Arm A.

EAY191-A2: Patients are assigned to 1 of 3 cohorts.

COHORT 1: PARP-inhibitor naive patients are assigned to Arm A.

ARM A: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

COHORT 2: PARP-inhibitor naive patients are randomized to 1 of 2 arms.

ARM B: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

ARM C: Patients receive olaparib PO BID on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients experiencing disease progression have the option to migrate to Cohort 3, Arm D. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

COHORT 3: PARP-inhibitor resistant patients are assigned to Arm D.

ARM D: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

EAY191-N5: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who experience progression may crossover to Arm II. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study.

ARM II: Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 and palbociclib PO QD on days 1-21 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

2900

Fase

  • Fase 2

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forenede Stater, 35233
        • Rekruttering
        • University of Alabama at Birmingham Cancer Center
        • Ledende efterforsker:
          • Rebecca C. Arend
        • Kontakt:
      • Mobile, Alabama, Forenede Stater, 36688
        • Rekruttering
        • University of South Alabama Mitchell Cancer Institute
        • Kontakt:
        • Ledende efterforsker:
          • Ahmed Abdalla
    • Alaska
      • Anchorage, Alaska, Forenede Stater, 99508
    • Arizona
      • Goodyear, Arizona, Forenede Stater, 85338
        • Rekruttering
        • CTCA at Western Regional Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 623-207-3000
        • Ledende efterforsker:
          • Sagun Shrestha
      • Kingman, Arizona, Forenede Stater, 86401
        • Rekruttering
        • Kingman Regional Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Khawaja S. Jahangir
      • Phoenix, Arizona, Forenede Stater, 85054
        • Suspenderet
        • Mayo Clinic Hospital in Arizona
    • Arkansas
      • Jonesboro, Arkansas, Forenede Stater, 72401
        • Rekruttering
        • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
        • Kontakt:
        • Ledende efterforsker:
          • Andrew J. Benefield
    • California
      • Arroyo Grande, California, Forenede Stater, 93420
        • Rekruttering
        • PCR Oncology
        • Kontakt:
        • Ledende efterforsker:
          • Khawaja S. Jahangir
      • Carmichael, California, Forenede Stater, 95608
      • Carmichael, California, Forenede Stater, 95608
      • Dublin, California, Forenede Stater, 94568
        • Aktiv, ikke rekrutterende
        • Epic Care-Dublin
      • Elk Grove, California, Forenede Stater, 95758
      • Encinitas, California, Forenede Stater, 92024
        • Rekruttering
        • UC San Diego Health System - Encinitas
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 760-536-7700
        • Ledende efterforsker:
          • Peter Vu
      • La Jolla, California, Forenede Stater, 92093
        • Rekruttering
        • UC San Diego Moores Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Peter Vu
      • Los Angeles, California, Forenede Stater, 90048
        • Rekruttering
        • Cedars-Sinai Medical Center
        • Ledende efterforsker:
          • Omid Hamid
        • Kontakt:
      • Los Angeles, California, Forenede Stater, 90025
        • Rekruttering
        • The Angeles Clinic and Research Institute - West Los Angeles Office
        • Kontakt:
        • Ledende efterforsker:
          • Omid Hamid
      • Martinez, California, Forenede Stater, 94553-3156
        • Aktiv, ikke rekrutterende
        • Contra Costa Regional Medical Center
      • Orange, California, Forenede Stater, 92868
        • Rekruttering
        • Children's Hospital of Orange County
        • Kontakt:
        • Ledende efterforsker:
          • Elyssa M. Rubin
      • Orange, California, Forenede Stater, 92868
        • Rekruttering
        • Saint Joseph Hospital - Orange
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 714-734-6220
        • Ledende efterforsker:
          • Timothy E. Byun
      • Palo Alto, California, Forenede Stater, 94304
        • Rekruttering
        • Stanford Cancer Institute Palo Alto
        • Ledende efterforsker:
          • James M. Ford
        • Kontakt:
      • Palo Alto, California, Forenede Stater, 94304
        • Rekruttering
        • VA Palo Alto Health Care System
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-455-0057
        • Ledende efterforsker:
          • Harlan A. Pinto
      • Rocklin, California, Forenede Stater, 95765
      • Sacramento, California, Forenede Stater, 95816
      • San Diego, California, Forenede Stater, 92103
        • Rekruttering
        • UC San Diego Medical Center - Hillcrest
        • Kontakt:
        • Ledende efterforsker:
          • Peter Vu
      • San Diego, California, Forenede Stater, 92123
        • Rekruttering
        • Sharp Memorial Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Charles H. Redfern
      • San Francisco, California, Forenede Stater, 94158
        • Suspenderet
        • UCSF Medical Center-Mission Bay
      • Santa Monica, California, Forenede Stater, 90404
        • Rekruttering
        • Saint John's Cancer Institute
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 310-582-7448
        • Ledende efterforsker:
          • Reva K. Basho
      • Walnut Creek, California, Forenede Stater, 94597
        • Aktiv, ikke rekrutterende
        • Epic Care Cyberknife Center
      • Whittier, California, Forenede Stater, 90602
        • Suspenderet
        • Presbyterian Intercommunity Hospital
      • Woodland, California, Forenede Stater, 95695
    • Colorado
      • Aurora, Colorado, Forenede Stater, 80045
        • Rekruttering
        • UCHealth University of Colorado Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 720-848-0650
        • Ledende efterforsker:
          • Bradley R. Corr
      • Fort Collins, Colorado, Forenede Stater, 80524
        • Rekruttering
        • Poudre Valley Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 970-297-6150
        • Ledende efterforsker:
          • Bradley R. Corr
      • Fort Collins, Colorado, Forenede Stater, 80528
        • Rekruttering
        • Cancer Care and Hematology-Fort Collins
        • Kontakt:
        • Ledende efterforsker:
          • Bradley R. Corr
      • Greeley, Colorado, Forenede Stater, 80631
        • Rekruttering
        • UCHealth Greeley Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Bradley R. Corr
      • Loveland, Colorado, Forenede Stater, 80538
        • Rekruttering
        • Medical Center of the Rockies
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 970-203-7083
        • Ledende efterforsker:
          • Bradley R. Corr
    • Delaware
      • Newark, Delaware, Forenede Stater, 19713
        • Rekruttering
        • Helen F Graham Cancer Center
        • Ledende efterforsker:
          • Gregory A. Masters
        • Kontakt:
      • Newark, Delaware, Forenede Stater, 19713
        • Rekruttering
        • Medical Oncology Hematology Consultants PA
        • Ledende efterforsker:
          • Gregory A. Masters
        • Kontakt:
    • Florida
      • Aventura, Florida, Forenede Stater, 33180
        • Rekruttering
        • UM Sylvester Comprehensive Cancer Center at Aventura
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 954-461-2180
        • Ledende efterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
      • Coral Gables, Florida, Forenede Stater, 33146
        • Rekruttering
        • UM Sylvester Comprehensive Cancer Center at Coral Gables
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 305-243-2647
        • Ledende efterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
      • Deerfield Beach, Florida, Forenede Stater, 33442
        • Rekruttering
        • UM Sylvester Comprehensive Cancer Center at Deerfield Beach
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 305-243-2647
        • Ledende efterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
      • Fort Lauderdale, Florida, Forenede Stater, 33316
        • Aktiv, ikke rekrutterende
        • Broward Health Medical Center
      • Gainesville, Florida, Forenede Stater, 32610
        • Rekruttering
        • UF Health Cancer Institute - Gainesville
        • Kontakt:
        • Ledende efterforsker:
          • Thomas J. George
      • Jacksonville, Florida, Forenede Stater, 32224-9980
        • Rekruttering
        • Mayo Clinic in Florida
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 855-776-0015
        • Ledende efterforsker:
          • Aaron S. Mansfield
      • Miami, Florida, Forenede Stater, 33136
        • Rekruttering
        • University of Miami Miller School of Medicine-Sylvester Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 305-243-2647
        • Ledende efterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
      • Miami, Florida, Forenede Stater, 33176
        • Rekruttering
        • UM Sylvester Comprehensive Cancer Center at Kendall
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 305-243-2647
        • Ledende efterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
      • North Miami, Florida, Forenede Stater, 33181
        • Rekruttering
        • University of Miami Sylvester Comprehensive Cancer Center at Sole Mia
        • Ledende efterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
        • Kontakt:
      • Plantation, Florida, Forenede Stater, 33324
        • Rekruttering
        • UM Sylvester Comprehensive Cancer Center at Plantation
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 305-243-2647
        • Ledende efterforsker:
          • Chukwuemeka (Emeka) V. Ikpeazu
    • Georgia
      • Newnan, Georgia, Forenede Stater, 30265
        • Aktiv, ikke rekrutterende
        • CTCA at Southeastern Regional Medical Center
    • Hawaii
      • Honolulu, Hawaii, Forenede Stater, 96826
        • Rekruttering
        • Kapiolani Medical Center for Women and Children
        • Ledende efterforsker:
          • Jeffrey L. Berenberg
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-983-6090
      • Honolulu, Hawaii, Forenede Stater, 96813
        • Rekruttering
        • Hawaii Cancer Care Inc - Waterfront Plaza
        • Ledende efterforsker:
          • Jeffrey L. Berenberg
        • Kontakt:
      • Honolulu, Hawaii, Forenede Stater, 96813
        • Rekruttering
        • Queen's Cancer Cenrer - POB I
        • Ledende efterforsker:
          • Jeffrey L. Berenberg
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-532-0315
      • Honolulu, Hawaii, Forenede Stater, 96813
        • Rekruttering
        • Queen's Medical Center
        • Ledende efterforsker:
          • Jeffrey L. Berenberg
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-545-8548
      • Honolulu, Hawaii, Forenede Stater, 96813
        • Rekruttering
        • Straub Clinic and Hospital
        • Ledende efterforsker:
          • Jeffrey L. Berenberg
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-522-4333
      • Honolulu, Hawaii, Forenede Stater, 96813
        • Rekruttering
        • University of Hawaii Cancer Center
        • Ledende efterforsker:
          • Jeffrey L. Berenberg
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-586-2979
      • Honolulu, Hawaii, Forenede Stater, 96817
        • Rekruttering
        • Queen's Cancer Center - Kuakini
        • Ledende efterforsker:
          • Jeffrey L. Berenberg
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-531-8521
      • ‘Aiea, Hawaii, Forenede Stater, 96701
        • Rekruttering
        • Hawaii Cancer Care - Westridge
        • Kontakt:
        • Ledende efterforsker:
          • Jeffrey L. Berenberg
      • ‘Aiea, Hawaii, Forenede Stater, 96701
        • Rekruttering
        • Pali Momi Medical Center
        • Ledende efterforsker:
          • Jeffrey L. Berenberg
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-486-6000
      • ‘Ewa Beach, Hawaii, Forenede Stater, 96706
        • Rekruttering
        • The Queen's Medical Center - West Oahu
        • Ledende efterforsker:
          • Jeffrey L. Berenberg
        • Kontakt:
    • Idaho
      • Boise, Idaho, Forenede Stater, 83712
        • Rekruttering
        • Saint Luke's Cancer Institute - Boise
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
      • Boise, Idaho, Forenede Stater, 83706
        • Rekruttering
        • Saint Alphonsus Cancer Care Center-Boise
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Caldwell, Idaho, Forenede Stater, 83605
        • Rekruttering
        • Saint Alphonsus Cancer Care Center-Caldwell
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Coeur d'Alene, Idaho, Forenede Stater, 83814
        • Rekruttering
        • Kootenai Health - Coeur d'Alene
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Fruitland, Idaho, Forenede Stater, 83619
        • Rekruttering
        • Saint Luke's Cancer Institute - Fruitland
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
      • Meridian, Idaho, Forenede Stater, 83642
        • Rekruttering
        • Saint Luke's Cancer Institute - Meridian
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
      • Nampa, Idaho, Forenede Stater, 83687
        • Rekruttering
        • Saint Luke's Cancer Institute - Nampa
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
      • Nampa, Idaho, Forenede Stater, 83687
        • Rekruttering
        • Saint Alphonsus Cancer Care Center-Nampa
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Post Falls, Idaho, Forenede Stater, 83854
        • Rekruttering
        • Kootenai Clinic Cancer Services - Post Falls
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Sandpoint, Idaho, Forenede Stater, 83864
        • Rekruttering
        • Kootenai Clinic Cancer Services - Sandpoint
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Twin Falls, Idaho, Forenede Stater, 83301
        • Rekruttering
        • Saint Luke's Cancer Institute - Twin Falls
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
    • Illinois
      • Barrington, Illinois, Forenede Stater, 60010
        • Rekruttering
        • Advocate Good Shepherd Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 847-842-4847
        • Ledende efterforsker:
          • Antony Ruggeri
      • Bloomington, Illinois, Forenede Stater, 61704
        • Rekruttering
        • Illinois CancerCare-Bloomington
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Canton, Illinois, Forenede Stater, 61520
        • Rekruttering
        • Illinois CancerCare-Canton
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Carterville, Illinois, Forenede Stater, 62918
        • Rekruttering
        • SIH Cancer Institute
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
      • Carthage, Illinois, Forenede Stater, 62321
        • Rekruttering
        • Illinois CancerCare-Carthage
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Centralia, Illinois, Forenede Stater, 62801
        • Rekruttering
        • Centralia Oncology Clinic
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
      • Chicago, Illinois, Forenede Stater, 60637
        • Rekruttering
        • University of Chicago Comprehensive Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Ardaman Shergill
      • Chicago, Illinois, Forenede Stater, 60611
        • Rekruttering
        • Northwestern University
        • Ledende efterforsker:
          • Devalingam Mahalingam
        • Kontakt:
      • Chicago, Illinois, Forenede Stater, 60612
        • Rekruttering
        • University of Illinois
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 312-355-3046
        • Ledende efterforsker:
          • Ryan Nguyen
      • Chicago, Illinois, Forenede Stater, 60612
        • Rekruttering
        • John H Stroger Jr Hospital of Cook County
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 312-864-5204
        • Ledende efterforsker:
          • Deimante M. Tamkus
      • Chicago, Illinois, Forenede Stater, 60657
        • Rekruttering
        • Advocate Illinois Masonic Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 773-296-5360
        • Ledende efterforsker:
          • Antony Ruggeri
      • Chicago, Illinois, Forenede Stater, 60608
        • Rekruttering
        • Mount Sinai Hospital Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 773-257-5960
          • E-mail: suhi@sinai.org
        • Ledende efterforsker:
          • Pam G. Khosla
      • Crystal Lake, Illinois, Forenede Stater, 60014
        • Rekruttering
        • AMG Crystal Lake - Oncology
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Danville, Illinois, Forenede Stater, 61832
        • Rekruttering
        • Carle at The Riverfront
        • Ledende efterforsker:
          • Tanmay Sahai
        • Kontakt:
      • DeKalb, Illinois, Forenede Stater, 60115
        • Rekruttering
        • Northwestern Medicine Cancer Center Kishwaukee
        • Ledende efterforsker:
          • Devalingam Mahalingam
        • Kontakt:
      • Decatur, Illinois, Forenede Stater, 62526
        • Rekruttering
        • Cancer Care Specialists of Illinois - Decatur
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
      • Decatur, Illinois, Forenede Stater, 62526
        • Rekruttering
        • Decatur Memorial Hospital
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
      • Dixon, Illinois, Forenede Stater, 61021
        • Rekruttering
        • Illinois CancerCare-Dixon
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 815-285-7800
      • Downers Grove, Illinois, Forenede Stater, 60515
        • Rekruttering
        • Advocate Good Samaritan Hospital
        • Ledende efterforsker:
          • Antony Ruggeri
        • Kontakt:
      • Effingham, Illinois, Forenede Stater, 62401
        • Rekruttering
        • Carle Physician Group-Effingham
        • Kontakt:
        • Ledende efterforsker:
          • Tanmay Sahai
      • Effingham, Illinois, Forenede Stater, 62401
        • Rekruttering
        • Crossroads Cancer Center
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
      • Elgin, Illinois, Forenede Stater, 60123
        • Rekruttering
        • Advocate Sherman Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 847-429-2907
        • Ledende efterforsker:
          • Antony Ruggeri
      • Eureka, Illinois, Forenede Stater, 61530
        • Rekruttering
        • Illinois CancerCare-Eureka
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Evanston, Illinois, Forenede Stater, 60201
        • Rekruttering
        • NorthShore University HealthSystem-Evanston Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 847-570-2109
        • Ledende efterforsker:
          • Mary T. Jenkins Vogel
      • Galesburg, Illinois, Forenede Stater, 61401
        • Rekruttering
        • Illinois CancerCare-Galesburg
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Geneva, Illinois, Forenede Stater, 60134
        • Rekruttering
        • Northwestern Medicine Cancer Center Delnor
        • Ledende efterforsker:
          • Devalingam Mahalingam
        • Kontakt:
      • Glenview, Illinois, Forenede Stater, 60026
        • Rekruttering
        • NorthShore University HealthSystem-Glenbrook Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 847-570-2109
        • Ledende efterforsker:
          • Mary T. Jenkins Vogel
      • Glenview, Illinois, Forenede Stater, 60026
        • Rekruttering
        • Northwestern Medicine Glenview Outpatient Center
        • Ledende efterforsker:
          • Devalingam Mahalingam
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 312-695-1102
      • Grayslake, Illinois, Forenede Stater, 60030
        • Rekruttering
        • Northwestern Medicine Grayslake Outpatient Center
        • Ledende efterforsker:
          • Devalingam Mahalingam
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 312-695-1102
      • Harvey, Illinois, Forenede Stater, 60426
        • Rekruttering
        • Ingalls Memorial Hospital
        • Ledende efterforsker:
          • James A. Wallace
        • Kontakt:
      • Hazel Crest, Illinois, Forenede Stater, 60429
        • Rekruttering
        • Advocate South Suburban Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 708-799-9995
        • Ledende efterforsker:
          • Antony Ruggeri
      • Highland Park, Illinois, Forenede Stater, 60035
        • Rekruttering
        • NorthShore University HealthSystem-Highland Park Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 847-570-2109
        • Ledende efterforsker:
          • Mary T. Jenkins Vogel
      • Kewanee, Illinois, Forenede Stater, 61443
        • Rekruttering
        • Illinois CancerCare-Kewanee Clinic
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Lake Forest, Illinois, Forenede Stater, 60045
        • Rekruttering
        • Northwestern Medicine Lake Forest Hospital
        • Ledende efterforsker:
          • Devalingam Mahalingam
        • Kontakt:
      • Libertyville, Illinois, Forenede Stater, 60048
        • Rekruttering
        • AMG Libertyville - Oncology
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Libertyville, Illinois, Forenede Stater, 60048
        • Rekruttering
        • Condell Memorial Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Macomb, Illinois, Forenede Stater, 61455
        • Rekruttering
        • Illinois CancerCare-Macomb
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Mattoon, Illinois, Forenede Stater, 61938
        • Rekruttering
        • Carle Physician Group-Mattoon/Charleston
        • Kontakt:
        • Ledende efterforsker:
          • Tanmay Sahai
      • Maywood, Illinois, Forenede Stater, 60153
        • Rekruttering
        • Loyola University Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 708-226-4357
        • Ledende efterforsker:
          • Nan Sethakorn
      • Mount Vernon, Illinois, Forenede Stater, 62864
        • Rekruttering
        • SSM Health Good Samaritan
        • Ledende efterforsker:
          • Jay W. Carlson
        • Kontakt:
      • New Lenox, Illinois, Forenede Stater, 60451
        • Rekruttering
        • UC Comprehensive Cancer Center at Silver Cross
        • Kontakt:
        • Ledende efterforsker:
          • Ardaman Shergill
      • Normal, Illinois, Forenede Stater, 61761
        • Rekruttering
        • Carle BroMenn Medical Center
        • Ledende efterforsker:
          • Tanmay Sahai
        • Kontakt:
      • Normal, Illinois, Forenede Stater, 61761
        • Rekruttering
        • Carle Cancer Institute Normal
        • Ledende efterforsker:
          • Tanmay Sahai
        • Kontakt:
      • O'Fallon, Illinois, Forenede Stater, 62269
        • Rekruttering
        • Cancer Care Center of O'Fallon
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
      • Oak Lawn, Illinois, Forenede Stater, 60453-2699
        • Rekruttering
        • Advocate Christ Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-323-8622
        • Ledende efterforsker:
          • Antony Ruggeri
      • Orland Park, Illinois, Forenede Stater, 60462
        • Rekruttering
        • University of Chicago Medicine-Orland Park
        • Kontakt:
        • Ledende efterforsker:
          • Ardaman Shergill
      • Orland Park, Illinois, Forenede Stater, 60462
      • Ottawa, Illinois, Forenede Stater, 61350
        • Rekruttering
        • Illinois CancerCare-Ottawa Clinic
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Park Ridge, Illinois, Forenede Stater, 60068
        • Rekruttering
        • Advocate Lutheran General Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 847-384-3621
        • Ledende efterforsker:
          • Antony Ruggeri
      • Pekin, Illinois, Forenede Stater, 61554
        • Rekruttering
        • Illinois CancerCare-Pekin
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Peoria, Illinois, Forenede Stater, 61615
        • Rekruttering
        • Illinois CancerCare-Peoria
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Peru, Illinois, Forenede Stater, 61354
        • Rekruttering
        • Illinois CancerCare-Peru
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Princeton, Illinois, Forenede Stater, 61356
        • Rekruttering
        • Illinois CancerCare-Princeton
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Rockford, Illinois, Forenede Stater, 61114
        • Rekruttering
        • Mercyhealth Cancer Institute - Rockford
        • Ledende efterforsker:
          • Mayur Narkhede
        • Kontakt:
      • Shiloh, Illinois, Forenede Stater, 62269
        • Rekruttering
        • Memorial Hospital East
        • Kontakt:
        • Ledende efterforsker:
          • Nusayba Bagegni
      • Springfield, Illinois, Forenede Stater, 62702
        • Rekruttering
        • Southern Illinois University School of Medicine
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 217-545-7929
      • Springfield, Illinois, Forenede Stater, 62702
        • Rekruttering
        • Springfield Clinic
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-444-7541
      • Springfield, Illinois, Forenede Stater, 62781
        • Rekruttering
        • Springfield Memorial Hospital
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
      • Urbana, Illinois, Forenede Stater, 61801
        • Rekruttering
        • Carle Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Tanmay Sahai
      • Warrenville, Illinois, Forenede Stater, 60555
        • Rekruttering
        • Northwestern Medicine Cancer Center Warrenville
        • Ledende efterforsker:
          • Devalingam Mahalingam
        • Kontakt:
      • Washington, Illinois, Forenede Stater, 61571
        • Rekruttering
        • Illinois CancerCare - Washington
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Zion, Illinois, Forenede Stater, 60099
        • Aktiv, ikke rekrutterende
        • Midwestern Regional Medical Center
    • Indiana
      • Crown Point, Indiana, Forenede Stater, 46307
        • Rekruttering
        • UChicago Medicine Northwest Indiana
        • Ledende efterforsker:
          • Ardaman Shergill
        • Kontakt:
      • Michigan City, Indiana, Forenede Stater, 46360
        • Rekruttering
        • Woodland Cancer Care Center
        • Kontakt:
        • Ledende efterforsker:
          • William H. Bae
      • Richmond, Indiana, Forenede Stater, 47374
        • Suspenderet
        • Reid Health
      • South Bend, Indiana, Forenede Stater, 46601
        • Aktiv, ikke rekrutterende
        • Memorial Hospital of South Bend
    • Iowa
      • Ankeny, Iowa, Forenede Stater, 50023
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Ankeny Clinic
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Ledende efterforsker:
          • Seema Harichand-Herdt
      • Cedar Rapids, Iowa, Forenede Stater, 52403
        • Rekruttering
        • Mercy Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 319-365-4673
        • Ledende efterforsker:
          • Deborah W. Wilbur
      • Cedar Rapids, Iowa, Forenede Stater, 52403
        • Rekruttering
        • Oncology Associates at Mercy Medical Center
        • Ledende efterforsker:
          • Deborah W. Wilbur
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 319-363-2690
      • Des Moines, Iowa, Forenede Stater, 50314
        • Rekruttering
        • Mercy Medical Center - Des Moines
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Ledende efterforsker:
          • Richard L. Deming
      • Des Moines, Iowa, Forenede Stater, 50309
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Ledende efterforsker:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Forenede Stater, 50314
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Ledende efterforsker:
          • Seema Harichand-Herdt
      • Waukee, Iowa, Forenede Stater, 50263
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Waukee Clinic
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Ledende efterforsker:
          • Seema Harichand-Herdt
    • Kentucky
      • Lexington, Kentucky, Forenede Stater, 40536
        • Rekruttering
        • University of Kentucky/Markey Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 859-257-3379
        • Ledende efterforsker:
          • Susanne M. Arnold
      • Lexington, Kentucky, Forenede Stater, 40509
        • Rekruttering
        • CommonSpirit Saint Joseph Medical Center - East Lexington
        • Ledende efterforsker:
          • Loretta J. Nastoupil
        • Kontakt:
      • Paducah, Kentucky, Forenede Stater, 42003
        • Aktiv, ikke rekrutterende
        • Mercy Health - Paducah Cancer Center
    • Louisiana
      • Metairie, Louisiana, Forenede Stater, 70006
        • Aktiv, ikke rekrutterende
        • East Jefferson General Hospital
      • New Orleans, Louisiana, Forenede Stater, 70121
        • Rekruttering
        • Ochsner Medical Center Jefferson
        • Ledende efterforsker:
          • John T. Cole
        • Kontakt:
      • New Orleans, Louisiana, Forenede Stater, 70112
        • Aktiv, ikke rekrutterende
        • University Medical Center New Orleans
    • Maine
      • Augusta, Maine, Forenede Stater, 04330
        • Rekruttering
        • Harold Alfond Center for Cancer Care
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 207-626-4855
        • Ledende efterforsker:
          • Leslie S. Bradford
      • Brewer, Maine, Forenede Stater, 04412
        • Rekruttering
        • Lafayette Family Cancer Center-EMMC
        • Ledende efterforsker:
          • Sarah J. Sinclair
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-987-3005
      • Scarborough, Maine, Forenede Stater, 04074
        • Rekruttering
        • MaineHealth Maine Medical Center- Scarborough
        • Ledende efterforsker:
          • Leslie S. Bradford
        • Kontakt:
      • South Portland, Maine, Forenede Stater, 04106
        • Rekruttering
        • MaineHealth Cancer Care and IV Therapy - South Portland
        • Ledende efterforsker:
          • Leslie S. Bradford
        • Kontakt:
    • Maryland
      • Baltimore, Maryland, Forenede Stater, 21201
        • Rekruttering
        • University of Maryland/Greenebaum Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-888-8823
        • Ledende efterforsker:
          • Ranee Mehra
      • Bethesda, Maryland, Forenede Stater, 20892
        • Rekruttering
        • National Institutes of Health Clinical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-411-1222
        • Ledende efterforsker:
          • A P. Chen
      • Bethesda, Maryland, Forenede Stater, 20889-5600
        • Rekruttering
        • Walter Reed National Military Medical Center
        • Ledende efterforsker:
          • Jeremy G. Perkins
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 301-319-2100
      • Cumberland, Maryland, Forenede Stater, 21502
        • Rekruttering
        • UPMC Western Maryland
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 240-964-1400
        • Ledende efterforsker:
          • Adam M. Brufsky
    • Massachusetts
      • Boston, Massachusetts, Forenede Stater, 02215
        • Rekruttering
        • Dana-Farber Cancer Institute
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-442-3324
        • Ledende efterforsker:
          • Geoffrey I. Shapiro
      • Boston, Massachusetts, Forenede Stater, 02111
      • Boston, Massachusetts, Forenede Stater, 02215
        • Aktiv, ikke rekrutterende
        • Beth Israel Deaconess Medical Center
      • Springfield, Massachusetts, Forenede Stater, 01199
        • Rekruttering
        • Baystate Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Tashanna K. Myers
      • Stoneham, Massachusetts, Forenede Stater, 02180
        • Rekruttering
        • Tufts Medical Center Cancer Center Stoneham
        • Ledende efterforsker:
          • Francis W. Nugent
        • Kontakt:
    • Michigan
      • Ann Arbor, Michigan, Forenede Stater, 48109
        • Rekruttering
        • University of Michigan Rogel Cancer Center
        • Ledende efterforsker:
          • Anne F. Schott
        • Kontakt:
      • Ann Arbor, Michigan, Forenede Stater, 48106
        • Rekruttering
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Battle Creek, Michigan, Forenede Stater, 49017
        • Rekruttering
        • Bronson Battle Creek
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Brighton, Michigan, Forenede Stater, 48114
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Brighton, Michigan, Forenede Stater, 48116
        • Rekruttering
        • University of Michigan - Brighton Center for Specialty Care
        • Ledende efterforsker:
          • Anne F. Schott
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-865-1125
      • Brighton, Michigan, Forenede Stater, 48114
        • Rekruttering
        • Trinity Health Medical Center - Brighton
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Canton, Michigan, Forenede Stater, 48188
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Canton, Michigan, Forenede Stater, 48188
        • Rekruttering
        • Trinity Health Medical Center - Canton
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Chelsea, Michigan, Forenede Stater, 48118
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Chelsea, Michigan, Forenede Stater, 48118
      • Dearborn, Michigan, Forenede Stater, 48124
        • Rekruttering
        • Corewell Health Dearborn Hospital
        • Ledende efterforsker:
          • Dana Zakalik
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 248-551-7695
      • Escanaba, Michigan, Forenede Stater, 49829
        • Rekruttering
        • OSF Saint Francis Hospital and Medical Group
        • Ledende efterforsker:
          • Brian L. Burnette
        • Kontakt:
      • Farmington Hills, Michigan, Forenede Stater, 48336
        • Suspenderet
        • Corewell Health Farmington Hills Hospital
      • Flint, Michigan, Forenede Stater, 48503
        • Rekruttering
        • Genesys Hurley Cancer Institute
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Flint, Michigan, Forenede Stater, 48503
        • Rekruttering
        • Hurley Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Flint, Michigan, Forenede Stater, 48503
        • Suspenderet
        • Genesee Hematology Oncology PC
      • Flint, Michigan, Forenede Stater, 48503
        • Rekruttering
        • Cancer Hematology Centers - Flint
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Grand Rapids, Michigan, Forenede Stater, 49503
        • Rekruttering
        • Trinity Health Grand Rapids Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Grand Rapids, Michigan, Forenede Stater, 49503
        • Rekruttering
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Kalamazoo, Michigan, Forenede Stater, 49007
        • Rekruttering
        • Bronson Methodist Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Kalamazoo, Michigan, Forenede Stater, 49007
        • Rekruttering
        • West Michigan Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Kalamazoo, Michigan, Forenede Stater, 49009
        • Rekruttering
        • Beacon Kalamazoo Cancer Center
        • Ledende efterforsker:
          • Kathleen Y. Butler
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 574-647-7370
      • Kalamazoo, Michigan, Forenede Stater, 49048
        • Rekruttering
        • Beacon Kalamazoo
        • Ledende efterforsker:
          • Kathleen Y. Butler
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 574-647-7370
      • Lansing, Michigan, Forenede Stater, 48912
        • Rekruttering
        • University of Michigan Health - Sparrow Lansing
        • Ledende efterforsker:
          • Tareq Al baghdadi
        • Kontakt:
      • Livonia, Michigan, Forenede Stater, 48154
        • Rekruttering
        • Trinity Health Saint Mary Mercy Livonia Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Macomb, Michigan, Forenede Stater, 48044
        • Rekruttering
        • Henry Ford Saint John Hospital - Macomb Medical
        • Ledende efterforsker:
          • Tareq Al baghdadi
        • Kontakt:
      • Manistique, Michigan, Forenede Stater, 49854
        • Rekruttering
        • Schoolcraft Memorial Hospital
        • Ledende efterforsker:
          • Brian L. Burnette
        • Kontakt:
      • Muskegon, Michigan, Forenede Stater, 49444
        • Rekruttering
        • Trinity Health Muskegon Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Niles, Michigan, Forenede Stater, 49120
        • Rekruttering
        • Corewell Health Lakeland Hospitals - Niles Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 616-391-1230
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Norton Shores, Michigan, Forenede Stater, 49444
        • Rekruttering
        • Cancer and Hematology Centers of Western Michigan - Norton Shores
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Pontiac, Michigan, Forenede Stater, 48341
        • Rekruttering
        • Trinity Health Saint Joseph Mercy Oakland Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Pontiac, Michigan, Forenede Stater, 48341
        • Rekruttering
        • Michigan Healthcare Professionals Pontiac
        • Ledende efterforsker:
          • Tareq Al baghdadi
        • Kontakt:
      • Reed City, Michigan, Forenede Stater, 49677
        • Rekruttering
        • Corewell Health Reed City Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Royal Oak, Michigan, Forenede Stater, 48073
        • Rekruttering
        • Corewell Health William Beaumont University Hospital
        • Ledende efterforsker:
          • Dana Zakalik
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 248-551-7695
      • Royal Oak, Michigan, Forenede Stater, 48073
        • Rekruttering
        • Corewell Health Children's
        • Ledende efterforsker:
          • Dana Zakalik
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 248-551-7695
      • Saginaw, Michigan, Forenede Stater, 48604
        • Suspenderet
        • Oncology Hematology Associates of Saginaw Valley PC
      • Saginaw, Michigan, Forenede Stater, 48601
      • Saint Joseph, Michigan, Forenede Stater, 49085
        • Rekruttering
        • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Saint Joseph, Michigan, Forenede Stater, 49085
        • Rekruttering
        • Corewell Health Lakeland Hospitals - Saint Joseph Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Tawas City, Michigan, Forenede Stater, 48764
      • Traverse City, Michigan, Forenede Stater, 49684
        • Rekruttering
        • Munson Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Troy, Michigan, Forenede Stater, 48085
        • Rekruttering
        • Corewell Health Beaumont Troy Hospital
        • Ledende efterforsker:
          • Dana Zakalik
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 248-551-7695
      • West Branch, Michigan, Forenede Stater, 48661
        • Suspenderet
        • Saint Mary's Oncology/Hematology Associates of West Branch
      • Wyoming, Michigan, Forenede Stater, 49519
        • Rekruttering
        • University of Michigan Health - West
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Ypsilanti, Michigan, Forenede Stater, 48106
      • Ypsilanti, Michigan, Forenede Stater, 48197
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
    • Minnesota
      • Bemidji, Minnesota, Forenede Stater, 56601
      • Coon Rapids, Minnesota, Forenede Stater, 55433
        • Rekruttering
        • Mercy Hospital
        • Kontakt:
        • Ledende efterforsker:
          • David M. King
      • Deer River, Minnesota, Forenede Stater, 56636
        • Rekruttering
        • Essentia Health - Deer River Clinic
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
      • Duluth, Minnesota, Forenede Stater, 55805
        • Rekruttering
        • Essentia Health Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
      • Edina, Minnesota, Forenede Stater, 55435
        • Rekruttering
        • Fairview Southdale Hospital
        • Kontakt:
        • Ledende efterforsker:
          • David M. King
      • Edina, Minnesota, Forenede Stater, 55435
        • Rekruttering
        • Minnesota Oncology - Edina
        • Kontakt:
        • Ledende efterforsker:
          • David M. King
      • Hibbing, Minnesota, Forenede Stater, 55746
        • Rekruttering
        • Essentia Health Hibbing Clinic
        • Ledende efterforsker:
          • Bret E. Friday
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 218-786-3308
      • Maple Grove, Minnesota, Forenede Stater, 55369
        • Rekruttering
        • Fairview Clinics and Surgery Center Maple Grove
        • Kontakt:
        • Ledende efterforsker:
          • David M. King
      • Maplewood, Minnesota, Forenede Stater, 55109
        • Rekruttering
        • Saint John's Hospital - Healtheast
        • Kontakt:
        • Ledende efterforsker:
          • David M. King
      • Minneapolis, Minnesota, Forenede Stater, 55407
        • Rekruttering
        • Abbott-Northwestern Hospital
        • Kontakt:
        • Ledende efterforsker:
          • David M. King
      • Rochester, Minnesota, Forenede Stater, 55905
        • Rekruttering
        • Mayo Clinic in Rochester
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 855-776-0015
        • Ledende efterforsker:
          • Aaron S. Mansfield
      • Saint Louis Park, Minnesota, Forenede Stater, 55416
        • Rekruttering
        • Park Nicollet Clinic - Saint Louis Park
        • Kontakt:
        • Ledende efterforsker:
          • David M. King
      • Saint Paul, Minnesota, Forenede Stater, 55101
        • Rekruttering
        • Regions Hospital
        • Kontakt:
        • Ledende efterforsker:
          • David M. King
      • Saint Paul, Minnesota, Forenede Stater, 55102
        • Rekruttering
        • United Hospital
        • Kontakt:
        • Ledende efterforsker:
          • David M. King
      • Sandstone, Minnesota, Forenede Stater, 55072
        • Rekruttering
        • Essentia Health Sandstone
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
      • Virginia, Minnesota, Forenede Stater, 55792
        • Rekruttering
        • Essentia Health Virginia Clinic
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
    • Mississippi
      • Columbus, Mississippi, Forenede Stater, 39705
        • Rekruttering
        • Baptist Memorial Hospital and Cancer Center-Golden Triangle
        • Kontakt:
        • Ledende efterforsker:
          • Andrew J. Benefield
      • Grenada, Mississippi, Forenede Stater, 38901
        • Rekruttering
        • Baptist Cancer Center-Grenada
        • Kontakt:
        • Ledende efterforsker:
          • Andrew J. Benefield
      • Gulfport, Mississippi, Forenede Stater, 39502
        • Aktiv, ikke rekrutterende
        • Gulfport Memorial Hospital
      • New Albany, Mississippi, Forenede Stater, 38652
        • Rekruttering
        • Baptist Memorial Hospital and Cancer Center-Union County
        • Kontakt:
        • Ledende efterforsker:
          • Andrew J. Benefield
      • Oxford, Mississippi, Forenede Stater, 38655
        • Rekruttering
        • Baptist Memorial Hospital and Cancer Center-Oxford
        • Kontakt:
        • Ledende efterforsker:
          • Andrew J. Benefield
      • Southhaven, Mississippi, Forenede Stater, 38671
        • Rekruttering
        • Baptist Memorial Hospital and Cancer Center-Desoto
        • Kontakt:
        • Ledende efterforsker:
          • Andrew J. Benefield
    • Missouri
      • Cape Girardeau, Missouri, Forenede Stater, 63703
        • Rekruttering
        • Saint Francis Medical Center
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 573-334-2230
          • E-mail: sfmc@sfmc.net
      • Chesterfield, Missouri, Forenede Stater, 63017
        • Rekruttering
        • Saint Luke's Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 314-205-6936
        • Ledende efterforsker:
          • Meera Rana
      • City of Saint Peters, Missouri, Forenede Stater, 63376
        • Rekruttering
        • Siteman Cancer Center at Saint Peters Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Nusayba Bagegni
      • Creve Coeur, Missouri, Forenede Stater, 63141
        • Rekruttering
        • Siteman Cancer Center at West County Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Nusayba Bagegni
      • Farmington, Missouri, Forenede Stater, 63640
        • Rekruttering
        • Parkland Health Center - Farmington
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 314-996-5569
      • Rolla, Missouri, Forenede Stater, 65401
        • Suspenderet
        • Phelps Health Delbert Day Cancer Institute
      • Saint Joseph, Missouri, Forenede Stater, 64506
        • Rekruttering
        • Heartland Regional Medical Center
        • Ledende efterforsker:
          • Jay W. Carlson
        • Kontakt:
      • Sainte Genevieve, Missouri, Forenede Stater, 63670
        • Rekruttering
        • Sainte Genevieve County Memorial Hospital
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 314-996-5569
      • Springfield, Missouri, Forenede Stater, 65804
        • Rekruttering
        • Mercy Hospital Springfield
        • Ledende efterforsker:
          • Jay W. Carlson
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 417-269-4520
      • Springfield, Missouri, Forenede Stater, 65807
        • Rekruttering
        • CoxHealth South Hospital
        • Ledende efterforsker:
          • Jay W. Carlson
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 417-269-4520
      • St Louis, Missouri, Forenede Stater, 63110
        • Rekruttering
        • Washington University School of Medicine
        • Kontakt:
        • Ledende efterforsker:
          • Nusayba Bagegni
      • St Louis, Missouri, Forenede Stater, 63128
        • Rekruttering
        • Mercy Hospital South
        • Ledende efterforsker:
          • Jay W. Carlson
        • Kontakt:
      • St Louis, Missouri, Forenede Stater, 63141
        • Rekruttering
        • Mercy Hospital Saint Louis
        • Ledende efterforsker:
          • Jay W. Carlson
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 314-251-7066
      • St Louis, Missouri, Forenede Stater, 63129
        • Rekruttering
        • Siteman Cancer Center-South County
        • Kontakt:
        • Ledende efterforsker:
          • Nusayba Bagegni
      • St Louis, Missouri, Forenede Stater, 63136
        • Rekruttering
        • Siteman Cancer Center at Christian Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Nusayba Bagegni
      • St Louis, Missouri, Forenede Stater, 63131
        • Rekruttering
        • Missouri Baptist Medical Center
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 314-996-5569
      • Sullivan, Missouri, Forenede Stater, 63080
        • Rekruttering
        • Missouri Baptist Sullivan Hospital
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 314-996-5569
    • Montana
      • Anaconda, Montana, Forenede Stater, 59711
        • Rekruttering
        • Community Hospital of Anaconda
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Billings, Montana, Forenede Stater, 59101
        • Rekruttering
        • Billings Clinic Cancer Center
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Bozeman, Montana, Forenede Stater, 59715
        • Rekruttering
        • Bozeman Health Deaconess Hospital
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Great Falls, Montana, Forenede Stater, 59405
        • Rekruttering
        • Benefis Sletten Cancer Institute
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Kalispell, Montana, Forenede Stater, 59901
        • Rekruttering
        • Logan Health Medical Center
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Missoula, Montana, Forenede Stater, 59804
        • Rekruttering
        • Community Medical Center
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
    • Nebraska
      • Bellevue, Nebraska, Forenede Stater, 68123
        • Aktiv, ikke rekrutterende
        • Nebraska Medicine-Bellevue
      • Omaha, Nebraska, Forenede Stater, 68198
        • Aktiv, ikke rekrutterende
        • University of Nebraska Medical Center
      • Omaha, Nebraska, Forenede Stater, 68118
        • Aktiv, ikke rekrutterende
        • Nebraska Medicine-Village Pointe
    • Nevada
      • Las Vegas, Nevada, Forenede Stater, 89102
        • Rekruttering
        • OptumCare Cancer Care at Charleston
        • Kontakt:
        • Ledende efterforsker:
          • Khawaja S. Jahangir
      • Las Vegas, Nevada, Forenede Stater, 89135
        • Rekruttering
        • Alliance for Childhood Diseases/Cure 4 the Kids Foundation
        • Kontakt:
        • Ledende efterforsker:
          • Khawaja S. Jahangir
      • Las Vegas, Nevada, Forenede Stater, 89144
        • Rekruttering
        • Summerlin Hospital Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Khawaja S. Jahangir
      • Las Vegas, Nevada, Forenede Stater, 89183
        • Suspenderet
        • OptumCare Cancer Care at Fort Apache
      • Reno, Nevada, Forenede Stater, 89502
        • Rekruttering
        • Renown Regional Medical Center
        • Ledende efterforsker:
          • Khawaja S. Jahangir
        • Kontakt:
    • New Jersey
      • Flemington, New Jersey, Forenede Stater, 08822
        • Rekruttering
        • Hunterdon Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 908-237-2330
        • Ledende efterforsker:
          • Myron E. Bednar
      • Lakewood, New Jersey, Forenede Stater, 08701
        • Rekruttering
        • Monmouth Medical Center Southern Campus
        • Ledende efterforsker:
          • Patrick M. Boland
        • Kontakt:
      • Livingston, New Jersey, Forenede Stater, 07039
        • Rekruttering
        • Cooperman Barnabas Medical Center
        • Ledende efterforsker:
          • Patrick M. Boland
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 973-322-5200
      • Long Branch, New Jersey, Forenede Stater, 07740
        • Rekruttering
        • Monmouth Medical Center
        • Ledende efterforsker:
          • Patrick M. Boland
        • Kontakt:
      • Middletown, New Jersey, Forenede Stater, 07748
        • Rekruttering
        • Memorial Sloan Kettering Monmouth
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Ledende efterforsker:
          • Alison M. Schram
      • New Brunswick, New Jersey, Forenede Stater, 08903
        • Rekruttering
        • Rutgers Cancer Institute of New Jersey
        • Ledende efterforsker:
          • Patrick M. Boland
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 732-235-7356
      • Pennington, New Jersey, Forenede Stater, 08534
        • Suspenderet
        • Capital Health Medical Center-Hopewell
      • Sewell, New Jersey, Forenede Stater, 08080
        • Rekruttering
        • Sidney Kimmel Cancer Center Washington Township
        • Kontakt:
        • Ledende efterforsker:
          • Jennifer M. Johnson
      • Somerville, New Jersey, Forenede Stater, 08876
        • Rekruttering
        • Robert Wood Johnson University Hospital Somerset
        • Ledende efterforsker:
          • Patrick M. Boland
        • Kontakt:
      • Toms River, New Jersey, Forenede Stater, 08755
        • Rekruttering
        • Community Medical Center
        • Ledende efterforsker:
          • Patrick M. Boland
        • Kontakt:
    • New Mexico
      • Albuquerque, New Mexico, Forenede Stater, 87106
        • Rekruttering
        • University of New Mexico Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Bernard Tawfik
    • New York
      • Buffalo, New York, Forenede Stater, 14263
        • Rekruttering
        • Roswell Park Cancer Institute
        • Kontakt:
        • Ledende efterforsker:
          • Ellis G. Levine
      • Commack, New York, Forenede Stater, 11725
        • Rekruttering
        • Memorial Sloan Kettering Commack
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Ledende efterforsker:
          • Alison M. Schram
      • Harrison, New York, Forenede Stater, 10604
        • Rekruttering
        • Memorial Sloan Kettering Westchester
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Ledende efterforsker:
          • Alison M. Schram
      • Mineola, New York, Forenede Stater, 11501
        • Rekruttering
        • NYU Langone Hospital - Long Island
        • Ledende efterforsker:
          • Kristen R. Spencer
        • Kontakt:
      • New York, New York, Forenede Stater, 10065
        • Rekruttering
        • Memorial Sloan Kettering Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Ledende efterforsker:
          • Alison M. Schram
      • New York, New York, Forenede Stater, 10016
        • Rekruttering
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
        • Ledende efterforsker:
          • Kristen R. Spencer
        • Kontakt:
      • New York, New York, Forenede Stater, 10029
        • Rekruttering
        • Mount Sinai Hospital
        • Ledende efterforsker:
          • Deborah B. Doroshow
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-824-7309
          • E-mail: CCTO@mssm.edu
      • Rochester, New York, Forenede Stater, 14623
        • Aktiv, ikke rekrutterende
        • Pluta Cancer Center
      • Syracuse, New York, Forenede Stater, 13210
        • Rekruttering
        • State University of New York Upstate Medical University
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 315-464-5476
        • Ledende efterforsker:
          • Mary J. Cunningham
      • The Bronx, New York, Forenede Stater, 10461
        • Rekruttering
        • Montefiore Medical Center-Einstein Campus
        • Kontakt:
        • Ledende efterforsker:
          • Balazs Halmos
      • The Bronx, New York, Forenede Stater, 10467
        • Rekruttering
        • Montefiore Medical Center - Moses Campus
        • Kontakt:
        • Ledende efterforsker:
          • Balazs Halmos
      • The Bronx, New York, Forenede Stater, 10461
        • Rekruttering
        • Montefiore Medical Center-Weiler Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Balazs Halmos
    • North Carolina
      • Asheboro, North Carolina, Forenede Stater, 27205
        • Rekruttering
        • Cone Health MedCenter Asheboro
        • Kontakt:
        • Ledende efterforsker:
          • Vinay K. Gudena
      • Burlington, North Carolina, Forenede Stater, 27215
        • Rekruttering
        • Cone Health Cancer Center at Alamance Regional
        • Kontakt:
        • Ledende efterforsker:
          • Vinay K. Gudena
      • Clinton, North Carolina, Forenede Stater, 28328
        • Rekruttering
        • Southeastern Medical Oncology Center-Clinton
        • Kontakt:
        • Ledende efterforsker:
          • Samer S. Kasbari
      • Durham, North Carolina, Forenede Stater, 27710
        • Rekruttering
        • Duke University Medical Center
        • Ledende efterforsker:
          • Angeles A. Secord
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 888-275-3853
      • Goldsboro, North Carolina, Forenede Stater, 27534
        • Rekruttering
        • Southeastern Medical Oncology Center-Goldsboro
        • Kontakt:
        • Ledende efterforsker:
          • Samer S. Kasbari
      • Greensboro, North Carolina, Forenede Stater, 27403
        • Rekruttering
        • Cone Health Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Vinay K. Gudena
      • Greensboro, North Carolina, Forenede Stater, 27410
        • Rekruttering
        • Cone Health Cancer Center at Drawbridge Parkway
        • Kontakt:
        • Ledende efterforsker:
          • Vinay K. Gudena
      • High Point, North Carolina, Forenede Stater, 27262
        • Rekruttering
        • Hayworth Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 336-802-2500
        • Ledende efterforsker:
          • Anna Kuan-Celarier
      • Jacksonville, North Carolina, Forenede Stater, 28546
        • Rekruttering
        • Southeastern Medical Oncology Center-Jacksonville
        • Ledende efterforsker:
          • Samer S. Kasbari
        • Kontakt:
      • Raleigh, North Carolina, Forenede Stater, 27607
        • Rekruttering
        • Duke Women's Cancer Care Raleigh
        • Ledende efterforsker:
          • Angeles A. Secord
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 919-785-4878
      • Reidsville, North Carolina, Forenede Stater, 27320
        • Rekruttering
        • Annie Penn Memorial Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Vinay K. Gudena
      • Winston-Salem, North Carolina, Forenede Stater, 27157
        • Rekruttering
        • Wake Forest University Health Sciences
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 336-713-6771
        • Ledende efterforsker:
          • Anna Kuan-Celarier
    • North Dakota
      • Bismarck, North Dakota, Forenede Stater, 58501
      • Fargo, North Dakota, Forenede Stater, 58122
      • Fargo, North Dakota, Forenede Stater, 58122
    • Ohio
      • Athens, Ohio, Forenede Stater, 45701
        • Rekruttering
        • OhioHealth O'Bleness Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Avon, Ohio, Forenede Stater, 44011
        • Rekruttering
        • UH Seidman Cancer Center at UH Avon Health Center
        • Ledende efterforsker:
          • Alberto J. Montero
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-641-2422
      • Beachwood, Ohio, Forenede Stater, 44122
        • Rekruttering
        • UHHS-Chagrin Highlands Medical Center
        • Ledende efterforsker:
          • Alberto J. Montero
        • Kontakt:
      • Belpre, Ohio, Forenede Stater, 45714
        • Rekruttering
        • Strecker Cancer Center-Belpre
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Canton, Ohio, Forenede Stater, 44710
        • Rekruttering
        • Aultman Health Foundation
        • Kontakt:
        • Ledende efterforsker:
          • Sunitha Vemulapalli
      • Centerville, Ohio, Forenede Stater, 45459
        • Rekruttering
        • Miami Valley Hospital South
        • Kontakt:
        • Ledende efterforsker:
          • Tarek M. Sabagh
      • Chillicothe, Ohio, Forenede Stater, 45601
        • Rekruttering
        • Adena Regional Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Cincinnati, Ohio, Forenede Stater, 45220
      • Cincinnati, Ohio, Forenede Stater, 45229
        • Aktiv, ikke rekrutterende
        • Cincinnati Children's Hospital Medical Center
      • Cleveland, Ohio, Forenede Stater, 44106
        • Rekruttering
        • Case Western Reserve University
        • Ledende efterforsker:
          • Alberto J. Montero
        • Kontakt:
      • Cleveland, Ohio, Forenede Stater, 44195
        • Aktiv, ikke rekrutterende
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Forenede Stater, 44111
        • Aktiv, ikke rekrutterende
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Columbus, Ohio, Forenede Stater, 43213
        • Rekruttering
        • Mount Carmel East Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Columbus, Ohio, Forenede Stater, 43214
        • Rekruttering
        • Columbus Oncology and Hematology Associates Inc
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Columbus, Ohio, Forenede Stater, 43214
        • Rekruttering
        • Riverside Methodist Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Columbus, Ohio, Forenede Stater, 43215
        • Rekruttering
        • Grant Medical Center
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Columbus, Ohio, Forenede Stater, 43219
        • Rekruttering
        • The Mark H Zangmeister Center
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Columbus, Ohio, Forenede Stater, 43228
        • Rekruttering
        • Doctors Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Columbus, Ohio, Forenede Stater, 43210
        • Rekruttering
        • Ohio State University Comprehensive Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Floor Backes
      • Dayton, Ohio, Forenede Stater, 45409
        • Rekruttering
        • Miami Valley Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Tarek M. Sabagh
      • Dayton, Ohio, Forenede Stater, 45415
        • Rekruttering
        • Miami Valley Hospital North
        • Kontakt:
        • Ledende efterforsker:
          • Tarek M. Sabagh
      • Dayton, Ohio, Forenede Stater, 45409
        • Rekruttering
        • Premier Blood and Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 937-276-8320
        • Ledende efterforsker:
          • Tarek M. Sabagh
      • Dayton, Ohio, Forenede Stater, 45415
        • Suspenderet
        • Dayton Physician LLC - Englewood
      • Delaware, Ohio, Forenede Stater, 43015
        • Rekruttering
        • Delaware Health Center-Grady Cancer Center
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Delaware, Ohio, Forenede Stater, 43015
        • Rekruttering
        • Grady Memorial Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Dublin, Ohio, Forenede Stater, 43016
        • Rekruttering
        • Columbus Oncology and Hematology Associates
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Dublin, Ohio, Forenede Stater, 43016
        • Rekruttering
        • Dublin Methodist Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Findlay, Ohio, Forenede Stater, 45840
        • Suspenderet
        • Armes Family Cancer Center
      • Franklin, Ohio, Forenede Stater, 45005-1066
        • Rekruttering
        • Atrium Medical Center-Middletown Regional Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Tarek M. Sabagh
      • Franklin, Ohio, Forenede Stater, 45005
        • Suspenderet
        • Dayton Physicians LLC-Atrium
      • Greenville, Ohio, Forenede Stater, 45331
        • Rekruttering
        • Miami Valley Cancer Care and Infusion
        • Ledende efterforsker:
          • Tarek M. Sabagh
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 937-569-7515
      • Grove City, Ohio, Forenede Stater, 43123
        • Rekruttering
        • Zangmeister Center Grove City
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Kettering, Ohio, Forenede Stater, 45429
        • Rekruttering
        • Kettering Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Howard M. Gross
      • Kettering, Ohio, Forenede Stater, 45409
        • Suspenderet
        • Greater Dayton Cancer Center
      • Lancaster, Ohio, Forenede Stater, 43130
        • Rekruttering
        • Fairfield Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Mansfield, Ohio, Forenede Stater, 44903
        • Rekruttering
        • OhioHealth Mansfield Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Marion, Ohio, Forenede Stater, 43302
        • Rekruttering
        • OhioHealth Marion General Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Marysville, Ohio, Forenede Stater, 43040
        • Rekruttering
        • Memorial Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Mayfield Heights, Ohio, Forenede Stater, 44124
        • Aktiv, ikke rekrutterende
        • Hillcrest Hospital Cancer Center
      • Mentor, Ohio, Forenede Stater, 44060
        • Rekruttering
        • UH Seidman Cancer Center at Lake Health Mentor Campus
        • Ledende efterforsker:
          • Alberto J. Montero
        • Kontakt:
      • Middleburg Heights, Ohio, Forenede Stater, 44130
        • Aktiv, ikke rekrutterende
        • UH Seidman Cancer Center at Southwest General Hospital
      • Mount Vernon, Ohio, Forenede Stater, 43050
        • Rekruttering
        • Knox Community Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Newark, Ohio, Forenede Stater, 43055
        • Rekruttering
        • Licking Memorial Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Perrysburg, Ohio, Forenede Stater, 43551
        • Rekruttering
        • Mercy Health - Perrysburg Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Pickerington, Ohio, Forenede Stater, 43147
        • Rekruttering
        • OhioHealth Pickerington Methodist Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Portsmouth, Ohio, Forenede Stater, 45662
        • Rekruttering
        • Southern Ohio Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Springfield, Ohio, Forenede Stater, 45504
        • Rekruttering
        • Springfield Regional Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Springfield, Ohio, Forenede Stater, 45504
        • Rekruttering
        • Springfield Regional Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Toledo, Ohio, Forenede Stater, 43623
        • Rekruttering
        • Mercy Health - Saint Anne Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Toledo, Ohio, Forenede Stater, 43623
        • Suspenderet
        • Toledo Clinic Cancer Centers-Toledo
      • Troy, Ohio, Forenede Stater, 45373
        • Rekruttering
        • Upper Valley Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Tarek M. Sabagh
      • Westerville, Ohio, Forenede Stater, 43081
        • Rekruttering
        • Saint Ann's Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
      • Westerville, Ohio, Forenede Stater, 43082
        • Rekruttering
        • OhioHealth Westerville Medical Campus/Westerville Cancer Center
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Youngstown, Ohio, Forenede Stater, 44501
        • Suspenderet
        • Saint Elizabeth Youngstown Hospital
      • Zanesville, Ohio, Forenede Stater, 43701
        • Rekruttering
        • Genesis Healthcare System Cancer Care Center
        • Kontakt:
        • Ledende efterforsker:
          • Aruna C. Gowda
    • Oklahoma
      • Oklahoma City, Oklahoma, Forenede Stater, 73104
        • Rekruttering
        • University of Oklahoma Health Sciences Center
        • Kontakt:
        • Ledende efterforsker:
          • Lauren E. Dockery
    • Oregon
      • Newberg, Oregon, Forenede Stater, 97132
        • Rekruttering
        • Providence Newberg Medical Center
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
      • Ontario, Oregon, Forenede Stater, 97914
        • Rekruttering
        • Saint Alphonsus Cancer Care Center-Ontario
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Oregon City, Oregon, Forenede Stater, 97045
        • Rekruttering
        • Providence Willamette Falls Medical Center
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
      • Portland, Oregon, Forenede Stater, 97239
        • Rekruttering
        • Oregon Health and Science University
        • Kontakt:
        • Ledende efterforsker:
          • Christopher W. Ryan
      • Portland, Oregon, Forenede Stater, 97213
        • Rekruttering
        • Providence Portland Medical Center
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
      • Portland, Oregon, Forenede Stater, 97225
        • Rekruttering
        • Providence Saint Vincent Medical Center
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
    • Pennsylvania
      • Allentown, Pennsylvania, Forenede Stater, 18103
        • Rekruttering
        • Lehigh Valley Hospital-Cedar Crest
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Altoona, Pennsylvania, Forenede Stater, 16601
      • Bethlehem, Pennsylvania, Forenede Stater, 18017
        • Rekruttering
        • Lehigh Valley Hospital - Muhlenberg
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Bryn Mawr, Pennsylvania, Forenede Stater, 19010
        • Rekruttering
        • Bryn Mawr Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Paul B. Gilman
      • East Stroudsburg, Pennsylvania, Forenede Stater, 18301
        • Rekruttering
        • Pocono Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Erie, Pennsylvania, Forenede Stater, 16505
        • Rekruttering
        • UPMC Hillman Cancer Center Erie
        • Ledende efterforsker:
          • Adam M. Brufsky
        • Kontakt:
      • Greensburg, Pennsylvania, Forenede Stater, 15601
        • Rekruttering
        • UPMC Cancer Centers - Arnold Palmer Pavilion
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 724-838-1900
        • Ledende efterforsker:
          • Adam M. Brufsky
      • Hazleton, Pennsylvania, Forenede Stater, 18201
        • Rekruttering
        • Lehigh Valley Hospital-Hazleton
        • Kontakt:
        • Ledende efterforsker:
          • Tareq Al baghdadi
      • Mechanicsburg, Pennsylvania, Forenede Stater, 17050
        • Rekruttering
        • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
        • Kontakt:
        • Ledende efterforsker:
          • Adam M. Brufsky
      • Media, Pennsylvania, Forenede Stater, 19063
        • Rekruttering
        • Riddle Memorial Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Paul B. Gilman
      • Monroeville, Pennsylvania, Forenede Stater, 15146
        • Rekruttering
        • UPMC Hillman Cancer Center - Monroeville
        • Ledende efterforsker:
          • Adam M. Brufsky
        • Kontakt:
      • Paoli, Pennsylvania, Forenede Stater, 19301
        • Rekruttering
        • Paoli Memorial Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Paul B. Gilman
      • Philadelphia, Pennsylvania, Forenede Stater, 19107
        • Rekruttering
        • Thomas Jefferson University Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Jennifer M. Johnson
      • Philadelphia, Pennsylvania, Forenede Stater, 19107
      • Philadelphia, Pennsylvania, Forenede Stater, 19111
        • Rekruttering
        • Fox Chase Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 215-728-4790
        • Ledende efterforsker:
          • Angela Jain
      • Pittsburgh, Pennsylvania, Forenede Stater, 15213
        • Rekruttering
        • UPMC-Magee Womens Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 412-647-2811
        • Ledende efterforsker:
          • Adam M. Brufsky
      • Pittsburgh, Pennsylvania, Forenede Stater, 15237
        • Rekruttering
        • UPMC-Passavant Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 412-367-6454
        • Ledende efterforsker:
          • Adam M. Brufsky
      • Pittsburgh, Pennsylvania, Forenede Stater, 15232
        • Rekruttering
        • UPMC Hillman Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 412-647-8073
        • Ledende efterforsker:
          • Adam M. Brufsky
      • Sayre, Pennsylvania, Forenede Stater, 18840
        • Rekruttering
        • Guthrie Medical Group PC-Robert Packer Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-836-0388
        • Ledende efterforsker:
          • Joyson Poulose
      • Willow Grove, Pennsylvania, Forenede Stater, 19090
        • Rekruttering
        • Asplundh Cancer Pavilion
        • Kontakt:
        • Ledende efterforsker:
          • Jennifer M. Johnson
      • Wynnewood, Pennsylvania, Forenede Stater, 19096
        • Rekruttering
        • Lankenau Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Paul B. Gilman
    • Rhode Island
      • Providence, Rhode Island, Forenede Stater, 02905
        • Rekruttering
        • Women and Infants Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 401-274-1122
        • Ledende efterforsker:
          • Paul A. DiSilvestro
      • Providence, Rhode Island, Forenede Stater, 02908
        • Rekruttering
        • Roger Williams Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Ritesh Rathore
    • South Carolina
      • Boiling Springs, South Carolina, Forenede Stater, 29316
        • Rekruttering
        • Prisma Health Cancer Institute - Spartanburg
        • Ledende efterforsker:
          • Ki Y. Chung
        • Kontakt:
      • Columbia, South Carolina, Forenede Stater, 29203
        • Rekruttering
        • Prisma Health Richland Hospital
        • Ledende efterforsker:
          • Ki Y. Chung
        • Kontakt:
      • Easley, South Carolina, Forenede Stater, 29640
        • Rekruttering
        • Prisma Health Cancer Institute - Easley
        • Ledende efterforsker:
          • Ki Y. Chung
        • Kontakt:
      • Greenville, South Carolina, Forenede Stater, 29605
        • Rekruttering
        • BI-LO Charities Children's Cancer Center
        • Ledende efterforsker:
          • Ki Y. Chung
        • Kontakt:
      • Greenville, South Carolina, Forenede Stater, 29601
        • Rekruttering
        • Saint Francis Hospital
        • Ledende efterforsker:
          • Stephen H. Dyar
        • Kontakt:
      • Greenville, South Carolina, Forenede Stater, 29605
        • Rekruttering
        • Prisma Health Cancer Institute - Faris
        • Ledende efterforsker:
          • Ki Y. Chung
        • Kontakt:
      • Greenville, South Carolina, Forenede Stater, 29607
        • Rekruttering
        • Saint Francis Cancer Center
        • Ledende efterforsker:
          • Stephen H. Dyar
        • Kontakt:
      • Greenville, South Carolina, Forenede Stater, 29605
        • Rekruttering
        • Prisma Health Cancer Institute - Butternut
        • Ledende efterforsker:
          • Ki Y. Chung
        • Kontakt:
      • Greenville, South Carolina, Forenede Stater, 29615
        • Rekruttering
        • Prisma Health Cancer Institute - Eastside
        • Ledende efterforsker:
          • Ki Y. Chung
        • Kontakt:
      • Greer, South Carolina, Forenede Stater, 29650
        • Rekruttering
        • Prisma Health Cancer Institute - Greer
        • Ledende efterforsker:
          • Ki Y. Chung
        • Kontakt:
      • Seneca, South Carolina, Forenede Stater, 29672
        • Rekruttering
        • Prisma Health Cancer Institute - Seneca
        • Ledende efterforsker:
          • Ki Y. Chung
        • Kontakt:
    • South Dakota
      • Rapid City, South Dakota, Forenede Stater, 57701
        • Aktiv, ikke rekrutterende
        • Rapid City Regional Hospital
      • Sioux Falls, South Dakota, Forenede Stater, 57104
      • Sioux Falls, South Dakota, Forenede Stater, 57117-5134
    • Tennessee
      • Collierville, Tennessee, Forenede Stater, 38017
        • Rekruttering
        • Baptist Memorial Hospital and Cancer Center-Collierville
        • Kontakt:
        • Ledende efterforsker:
          • Andrew J. Benefield
      • Johnson City, Tennessee, Forenede Stater, 37604
        • Rekruttering
        • Regional Cancer Center at Johnson City Medical Center
        • Ledende efterforsker:
          • Asheesh Shipstone
        • Kontakt:
      • Kingsport, Tennessee, Forenede Stater, 37660
        • Rekruttering
        • Ballad Health Cancer Care - Kingsport
        • Ledende efterforsker:
          • Asheesh Shipstone
        • Kontakt:
      • Memphis, Tennessee, Forenede Stater, 38120
        • Rekruttering
        • Baptist Memorial Hospital and Cancer Center-Memphis
        • Kontakt:
        • Ledende efterforsker:
          • Andrew J. Benefield
      • Nashville, Tennessee, Forenede Stater, 37232
        • Rekruttering
        • Vanderbilt University/Ingram Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-811-8480
        • Ledende efterforsker:
          • Jennifer H. Choe
      • Nashville, Tennessee, Forenede Stater, 37204
        • Rekruttering
        • Vanderbilt Breast Center at One Hundred Oaks
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-811-8480
        • Ledende efterforsker:
          • Jennifer H. Choe
    • Texas
      • Abilene, Texas, Forenede Stater, 79601
        • Rekruttering
        • Hendrick Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 325-670-6340
        • Ledende efterforsker:
          • Jose C. Velasco Di Domenico
      • Dallas, Texas, Forenede Stater, 75390
        • Rekruttering
        • UT Southwestern/Simmons Cancer Center-Dallas
        • Kontakt:
        • Ledende efterforsker:
          • Devin E. Jones
      • Houston, Texas, Forenede Stater, 77030
        • Aktiv, ikke rekrutterende
        • Houston Methodist Hospital
      • Houston, Texas, Forenede Stater, 77026-1967
        • Rekruttering
        • Lyndon Baines Johnson General Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 713-566-5000
        • Ledende efterforsker:
          • Funda Meric-Bernstam
      • Houston, Texas, Forenede Stater, 77030
        • Rekruttering
        • UT MD Anderson Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Funda Meric-Bernstam
      • Houston, Texas, Forenede Stater, 77070
        • Aktiv, ikke rekrutterende
        • Methodist Willowbrook Hospital
      • Houston, Texas, Forenede Stater, 77094
        • Aktiv, ikke rekrutterende
        • Houston Methodist West Hospital
      • Lubbock, Texas, Forenede Stater, 79410
        • Aktiv, ikke rekrutterende
        • Covenant Medical Center-Lakeside
      • Nassau Bay, Texas, Forenede Stater, 77058
        • Aktiv, ikke rekrutterende
        • Houston Methodist Saint John Hospital
      • Sugar Land, Texas, Forenede Stater, 77479
        • Aktiv, ikke rekrutterende
        • Houston Methodist Sugar Land Hospital
      • Temple, Texas, Forenede Stater, 76508
        • Rekruttering
        • Scott and White Memorial Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 254-724-5407
        • Ledende efterforsker:
          • Lucas Wong
      • The Woodlands, Texas, Forenede Stater, 77385
        • Aktiv, ikke rekrutterende
        • Houston Methodist The Woodlands Hospital
    • Virginia
      • Bristol, Virginia, Forenede Stater, 24201
        • Rekruttering
        • Ballad Health Cancer Care - Bristol
        • Ledende efterforsker:
          • Asheesh Shipstone
        • Kontakt:
      • Charlottesville, Virginia, Forenede Stater, 22908
      • Fairfax, Virginia, Forenede Stater, 22031
        • Rekruttering
        • Inova Schar Cancer Institute
        • Ledende efterforsker:
          • Timothy L. Cannon
        • Kontakt:
      • Falls Church, Virginia, Forenede Stater, 22042
        • Rekruttering
        • Inova Fairfax Hospital
        • Ledende efterforsker:
          • Timothy L. Cannon
        • Kontakt:
      • Richmond, Virginia, Forenede Stater, 23235
        • Rekruttering
        • VCU Massey Cancer Center at Stony Point
        • Kontakt:
        • Ledende efterforsker:
          • Andrew Poklepovic
      • Richmond, Virginia, Forenede Stater, 23229
        • Aktiv, ikke rekrutterende
        • Virginia Cancer Institute
      • Richmond, Virginia, Forenede Stater, 23229
        • Rekruttering
        • Henrico Doctor's Hospital
        • Ledende efterforsker:
          • Andrew S. Kennedy
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 804-591-4152
      • Richmond, Virginia, Forenede Stater, 23298
        • Rekruttering
        • VCU Massey Comprehensive Cancer Center
        • Ledende efterforsker:
          • Andrew Poklepovic
        • Kontakt:
      • Roanoke, Virginia, Forenede Stater, 24033
        • Rekruttering
        • Carilion Roanoke Memorial Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 540-985-8510
        • Ledende efterforsker:
          • Andrew Poklepovic
      • South Hill, Virginia, Forenede Stater, 23970
        • Rekruttering
        • VCU Community Memorial Health Center
        • Kontakt:
        • Ledende efterforsker:
          • Andrew Poklepovic
    • Washington
      • Edmonds, Washington, Forenede Stater, 98026
        • Rekruttering
        • Swedish Cancer Institute-Edmonds
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
      • Issaquah, Washington, Forenede Stater, 98029
        • Rekruttering
        • Swedish Cancer Institute-Issaquah
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
      • Lacey, Washington, Forenede Stater, 98503
        • Rekruttering
        • Providence Regional Cancer System-Lacey
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
      • Renton, Washington, Forenede Stater, 98055
        • Rekruttering
        • Valley Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Khawaja S. Jahangir
      • Seattle, Washington, Forenede Stater, 98122
        • Rekruttering
        • Swedish Medical Center-First Hill
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
      • Walla Walla, Washington, Forenede Stater, 99362
        • Rekruttering
        • Providence Saint Mary Regional Cancer Center
        • Ledende efterforsker:
          • Alison K. Conlin
        • Kontakt:
      • Yakima, Washington, Forenede Stater, 98902
        • Rekruttering
        • North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Khawaja S. Jahangir
    • West Virginia
      • Charleston, West Virginia, Forenede Stater, 25304
        • Rekruttering
        • Vandalia Health/CAMC Institute for Academic Medicine
        • Ledende efterforsker:
          • Ahmed A. Khalid
        • Kontakt:
      • Huntington, West Virginia, Forenede Stater, 25701
        • Rekruttering
        • Edwards Comprehensive Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Toni O. Pacioles
      • Morgantown, West Virginia, Forenede Stater, 26506
        • Rekruttering
        • West Virginia University Healthcare
        • Kontakt:
        • Ledende efterforsker:
          • Mohammed Almubarak
    • Wisconsin
      • Appleton, Wisconsin, Forenede Stater, 54911
        • Rekruttering
        • ThedaCare Regional Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Matthias Weiss
      • Appleton, Wisconsin, Forenede Stater, 54911
        • Rekruttering
        • ThedaCare Regional Medical Center - Appleton
        • Kontakt:
        • Ledende efterforsker:
          • Matthias Weiss
      • Ashland, Wisconsin, Forenede Stater, 54806
        • Rekruttering
        • Duluth Clinic Ashland
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
      • Berlin, Wisconsin, Forenede Stater, 54923
        • Rekruttering
        • ThedaCare Cancer Care - Berlin
        • Kontakt:
        • Ledende efterforsker:
          • Matthias Weiss
      • Burlington, Wisconsin, Forenede Stater, 53105
        • Rekruttering
        • Aurora Cancer Care-Southern Lakes VLCC
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Eau Claire, Wisconsin, Forenede Stater, 54701
      • Germantown, Wisconsin, Forenede Stater, 53022
        • Rekruttering
        • Aurora Health Care Germantown Health Center
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Grafton, Wisconsin, Forenede Stater, 53024
        • Rekruttering
        • Aurora Cancer Care-Grafton
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Green Bay, Wisconsin, Forenede Stater, 54311
        • Rekruttering
        • Aurora BayCare Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Green Bay, Wisconsin, Forenede Stater, 54301
        • Rekruttering
        • Saint Vincent Hospital Cancer Center Green Bay
        • Ledende efterforsker:
          • Brian L. Burnette
        • Kontakt:
      • Green Bay, Wisconsin, Forenede Stater, 54303
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Saint Mary's
        • Ledende efterforsker:
          • Brian L. Burnette
        • Kontakt:
      • Janesville, Wisconsin, Forenede Stater, 53548
        • Rekruttering
        • Mercyhealth Hospital and Cancer Center - Janesville
        • Kontakt:
        • Ledende efterforsker:
          • Emily G. Robinson
      • Kenosha, Wisconsin, Forenede Stater, 53142
        • Rekruttering
        • Aurora Cancer Care-Kenosha South
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • La Crosse, Wisconsin, Forenede Stater, 54601
        • Rekruttering
        • Gundersen Lutheran Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Kurt Oettel
      • Madison, Wisconsin, Forenede Stater, 53792
        • Rekruttering
        • University of Wisconsin Carbone Cancer Center - University Hospital
        • Ledende efterforsker:
          • Nataliya V. Uboha
        • Kontakt:
      • Madison, Wisconsin, Forenede Stater, 53718
        • Rekruttering
        • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
        • Ledende efterforsker:
          • Nataliya V. Uboha
        • Kontakt:
      • Marinette, Wisconsin, Forenede Stater, 54143
        • Rekruttering
        • Aurora Bay Area Medical Group-Marinette
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Marshfield, Wisconsin, Forenede Stater, 54449
      • Milwaukee, Wisconsin, Forenede Stater, 53209
        • Rekruttering
        • Aurora Cancer Care-Milwaukee
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Milwaukee, Wisconsin, Forenede Stater, 53215
        • Rekruttering
        • Aurora Saint Luke's Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Milwaukee, Wisconsin, Forenede Stater, 53233
        • Rekruttering
        • Aurora Sinai Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Minocqua, Wisconsin, Forenede Stater, 54548
      • Mukwonago, Wisconsin, Forenede Stater, 53149
        • Rekruttering
        • ProHealth D N Greenwald Center
        • Kontakt:
        • Ledende efterforsker:
          • Timothy R. Wassenaar
      • Neenah, Wisconsin, Forenede Stater, 54956
        • Rekruttering
        • ThedaCare Regional Medical Center - Neenah
        • Kontakt:
        • Ledende efterforsker:
          • Matthias Weiss
      • New London, Wisconsin, Forenede Stater, 54961
        • Rekruttering
        • ThedaCare Cancer Care - New London
        • Kontakt:
        • Ledende efterforsker:
          • Matthias Weiss
      • New Richmond, Wisconsin, Forenede Stater, 54017
        • Rekruttering
        • Cancer Center of Western Wisconsin
        • Kontakt:
        • Ledende efterforsker:
          • David M. King
      • Oconomowoc, Wisconsin, Forenede Stater, 53066
        • Rekruttering
        • ProHealth Oconomowoc Memorial Hospital
        • Ledende efterforsker:
          • Timothy R. Wassenaar
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 262-928-7878
      • Oconto Falls, Wisconsin, Forenede Stater, 54154
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Oconto Falls
        • Ledende efterforsker:
          • Brian L. Burnette
        • Kontakt:
      • Oshkosh, Wisconsin, Forenede Stater, 54904
        • Rekruttering
        • Vince Lombardi Cancer Clinic - Oshkosh
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Oshkosh, Wisconsin, Forenede Stater, 54904
        • Rekruttering
        • ThedaCare Cancer Care - Oshkosh
        • Kontakt:
        • Ledende efterforsker:
          • Matthias Weiss
      • Racine, Wisconsin, Forenede Stater, 53406
        • Rekruttering
        • Aurora Cancer Care-Racine
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Rice Lake, Wisconsin, Forenede Stater, 54868
      • Shawano, Wisconsin, Forenede Stater, 54166
        • Rekruttering
        • ThedaCare Cancer Care - Shawano
        • Kontakt:
        • Ledende efterforsker:
          • Matthias Weiss
      • Sheboygan, Wisconsin, Forenede Stater, 53081
        • Rekruttering
        • Vince Lombardi Cancer Clinic-Sheboygan
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Sheboygan, Wisconsin, Forenede Stater, 53081
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Sheboygan
        • Ledende efterforsker:
          • Brian L. Burnette
        • Kontakt:
      • Sheboygan, Wisconsin, Forenede Stater, 53081
        • Rekruttering
        • Sheboygan Physicians Group
        • Ledende efterforsker:
          • Brian L. Burnette
        • Kontakt:
      • Stevens Point, Wisconsin, Forenede Stater, 54482
      • Sturgeon Bay, Wisconsin, Forenede Stater, 54235-1495
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Sturgeon Bay
        • Ledende efterforsker:
          • Brian L. Burnette
        • Kontakt:
      • Summit, Wisconsin, Forenede Stater, 53066
        • Rekruttering
        • Aurora Medical Center in Summit
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Two Rivers, Wisconsin, Forenede Stater, 54241
        • Rekruttering
        • Vince Lombardi Cancer Clinic-Two Rivers
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Waukesha, Wisconsin, Forenede Stater, 53188
        • Rekruttering
        • UW Cancer Center at ProHealth Care
        • Ledende efterforsker:
          • Timothy R. Wassenaar
        • Kontakt:
      • Waupaca, Wisconsin, Forenede Stater, 54981
        • Rekruttering
        • ThedaCare Cancer Care - Waupaca
        • Kontakt:
        • Ledende efterforsker:
          • Matthias Weiss
      • Wauwatosa, Wisconsin, Forenede Stater, 53226
        • Rekruttering
        • Aurora Cancer Care-Milwaukee West
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • West Allis, Wisconsin, Forenede Stater, 53227
        • Rekruttering
        • Aurora West Allis Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Antony Ruggeri
      • Weston, Wisconsin, Forenede Stater, 54476
      • Bayamón, Puerto Rico, 00961
        • Rekruttering
        • Puerto Rico Hematology Oncology Group
        • Ledende efterforsker:
          • Luis J. Santos Reyes
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 787-780-2865
      • Manati, Puerto Rico, 00674
        • Rekruttering
        • Doctors Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 787-621-4397
        • Ledende efterforsker:
          • Luis J. Santos Reyes
      • San Juan, Puerto Rico, 00927
        • Rekruttering
        • Centro Comprensivo de Cancer de UPR
        • Ledende efterforsker:
          • Luis J. Santos Reyes
        • Kontakt:
      • San Juan, Puerto Rico, 00927
        • Rekruttering
        • PROncology
        • Ledende efterforsker:
          • Luis J. Santos Reyes
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn
  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Patient must have measurable disease

  • Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status between 0-2 OR patient must have Lansky performance status of >= 50% or Karnofsky performance status of >= 50%

  • Patient must be deemed potentially eligible for a ComboMATCH Treatment Trial as assessed by the enrolling provider

  • All patients must have sequencing results available from a National Cancer Institute (NCI) credentialed Designated Laboratory (DL)

  • Patients must have locally advanced or advanced histologically documented solid tumors requiring therapy and meet one of the following criteria:

    • Patients must have progressed on at least one line of standard systemic therapy OR
    • Patients whose disease has no standard treatment that has been shown to prolong overall survival
  • Patient must meet one of the following requirements:

    • Patients 18 years and older who have tumor amenable to minimal risk image-guided or direct vision biopsy and must be willing and able to undergo a tumor biopsy to obtain samples for research if the patient is to enroll in a ComboMATCH treatment trial OR

    • Patients 18 years and older who do not have disease that is biopsiable at minimal risk to the patient must confirm availability of an archival tumor tissue specimen for submission for research if the patient enrolls to a ComboMATCH Treatment Trial. This tumor tissue must meet the following criteria:

      • Tissue must have been collected within 12 months prior to registration to the EAY191 Registration Trial
      • Patient must not have had a Response Evaluation Criteria in Solid Tumors (RECIST) response (complete response [CR] or partial response [PR]) to any intervening therapy after collection of the tissue
      • Formalin-fixed paraffin-embedded tumor tissue block(s) or slides must be available OR
    • Patients under 18 years old must confirm availability of an archival tumor tissue specimen for submission for research if patient enrolls to a ComboMATCH Treatment Trial. This tumor tissue must meet the following criteria:

      • Formalin-fixed paraffin-embedded tumor tissue block(s) or slides must be available
    • NOTE: See specific ComboMATCH Treatment Trial protocol for tissue collection and management instructions. Performance of the mandatory research biopsy or submission of pre-trial formalin-fixed paraffin-embedded (FFPE) and collection and submission of the blood specimens for the integrated studies will be performed under the consent authority of the specific treatment trial protocol to which the patient is registered. No procedures to collect specimens for research only are to be performed for patients registered to the EAY191 Registration Trial only

  • NOTE: Each ComboMATCH Treatment Trial contains specific eligibility criteria. If patient is found to not be eligible for the assigned ComboMATCH Treatment Trial, indication of ineligibility will trigger re-evaluation and potential assignment to another Treatment Trial

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Screening
  • Tildeling: Randomiseret
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: EAY191-A2 (Cohort 1, Arm A)

Cohort 1, Arm A: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo PET

Andre navne:
  • Medicinsk billeddannelse, Positron Emission Tomografi
  • KÆLEDYR
  • PET-scanning
  • Positron Emission Tomografi Scan
  • Positron-emissionstomografi
  • PT
  • Positron emissionstomografi (procedure)

Given PO

Andre navne:
  • Lynparza
  • AZD 2281
  • AZD-2281
  • AZD2281
  • KU-0059436
  • PARP-hæmmer AZD2281
  • KU0059436
  • Olanib
  • Olaparix
  • KU 0059436

Undergo bone scan

Andre navne:
  • Knoglescintigrafi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Given PO

Andre navne:
  • Piqray
  • BYL719
  • Phosphoinositide 3-kinase hæmmer BYL719
  • VIJOICE
  • BYL 719
  • BYL-719
Eksperimentel: EAY191-A2 (Cohort 2, Arm B)

Cohort 2, Arm B: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo PET

Andre navne:
  • Medicinsk billeddannelse, Positron Emission Tomografi
  • KÆLEDYR
  • PET-scanning
  • Positron Emission Tomografi Scan
  • Positron-emissionstomografi
  • PT
  • Positron emissionstomografi (procedure)

Given PO

Andre navne:
  • Lynparza
  • AZD 2281
  • AZD-2281
  • AZD2281
  • KU-0059436
  • PARP-hæmmer AZD2281
  • KU0059436
  • Olanib
  • Olaparix
  • KU 0059436

Undergo bone scan

Andre navne:
  • Knoglescintigrafi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Given PO

Andre navne:
  • Piqray
  • BYL719
  • Phosphoinositide 3-kinase hæmmer BYL719
  • VIJOICE
  • BYL 719
  • BYL-719
Eksperimentel: EAY191-A2 (Cohort 2, Arm C)

Cohort 2, Arm C: Patients receive olaparib PO BID on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients experiencing disease progression have the option to migrate to Cohort 3, Arm D. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo PET

Andre navne:
  • Medicinsk billeddannelse, Positron Emission Tomografi
  • KÆLEDYR
  • PET-scanning
  • Positron Emission Tomografi Scan
  • Positron-emissionstomografi
  • PT
  • Positron emissionstomografi (procedure)

Given PO

Andre navne:
  • Lynparza
  • AZD 2281
  • AZD-2281
  • AZD2281
  • KU-0059436
  • PARP-hæmmer AZD2281
  • KU0059436
  • Olanib
  • Olaparix
  • KU 0059436

Undergo bone scan

Andre navne:
  • Knoglescintigrafi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion
Eksperimentel: EAY191-A2 (Cohort 3, Arm D)

Cohort 3, Arm D: Patients receive olaparib PO BID and alpelisib PO daily on days 1-28 of each cycle. Cycles repeat every 28 days for up to 5 years in the absence of disease progression, unacceptable toxicity, or bone marrow findings consistent with MDS or AML. Patients also undergo MRI, CT, and/or PET scans throughout the trial and a biopsy prior to treatment start. Patients may also undergo bone scans on study as clinically indicated. Patients have the option to also undergo blood collection throughout the trial and a second biopsy at time of disease progression.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo PET

Andre navne:
  • Medicinsk billeddannelse, Positron Emission Tomografi
  • KÆLEDYR
  • PET-scanning
  • Positron Emission Tomografi Scan
  • Positron-emissionstomografi
  • PT
  • Positron emissionstomografi (procedure)

Given PO

Andre navne:
  • Lynparza
  • AZD 2281
  • AZD-2281
  • AZD2281
  • KU-0059436
  • PARP-hæmmer AZD2281
  • KU0059436
  • Olanib
  • Olaparix
  • KU 0059436

Undergo bone scan

Andre navne:
  • Knoglescintigrafi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Given PO

Andre navne:
  • Piqray
  • BYL719
  • Phosphoinositide 3-kinase hæmmer BYL719
  • VIJOICE
  • BYL 719
  • BYL-719
Eksperimentel: EAY191-A3 Combo Cohorts 1, 2, 3, 4 (palbociclib, binimetinib)

Patients receive palbociclib PO and binimetinib PO throughout the trial. Patients may also undergo biopsy at screening and undergo MRI, CT, bone scan, and collection of blood samples during screening, on study, and/or during follow up.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given PO

Andre navne:
  • Ibrance
  • 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-on
  • PD 0332991
  • PD 332991
  • PD 991
  • PD-0332991
  • PD0332991

Undergo bone scan

Andre navne:
  • Knoglescintigrafi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion
Eksperimentel: EAY191-A3 Monotherapy Cohort 1 (binimetinib)

Patients receive binimetinib PO throughout the trial. Patients may also undergo biopsy at screening and undergo MRI, CT, bone scan, and collection of blood samples during screening, on study, and/or during follow up.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given PO

Andre navne:
  • ARRY-162
  • ARRY-438162
  • MEK162
  • Mektovi
  • ARRY 438162
  • ARRY 162
  • ARRY162
  • ARRY438162
  • MEK 162
  • MEK-162

Undergo bone scan

Andre navne:
  • Knoglescintigrafi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion
Eksperimentel: EAY191-A6 Arm I (RAS/RAF/MEK/ERK mutations)

Patients receive leucovorin IV, oxaliplatin IV, and fluorouracil IV on study. Patients undergo ECHO and MUGA during screening and on study, a CT with contrast, MRI, or a FDG-PET during screening, collection of blood during screening and on study, and a biopsy during screening. Patients may also undergo brain MRI or CT during screening and on study, bone scans on study, and biopsy on study if clinically indicated.

Given IV

Andre navne:
  • 5-Fluracil
  • Fluracil
  • 5 Fluorouracil
  • 5 Fluorouracilum
  • 5 FU
  • 5-fluor-2,4(1H,3H)-pyrimidindion
  • 5-Fluorouracil
  • 5-Fu
  • 5FU
  • AccuSite
  • Carac
  • Fluor Uracil
  • Fluouracil
  • Flurablastin
  • Fluracedyl
  • Fluril
  • Fluroblastin
  • Ribofluor
  • Ro 2-9757
  • Ro-2-9757

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo ECHO

Andre navne:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navne:
  • Blood Pool Scan
  • Ligevægtsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-scanning
  • Synkroniseret Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid Ventrikulogram Scan
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo PET

Andre navne:
  • Medicinsk billeddannelse, Positron Emission Tomografi
  • KÆLEDYR
  • PET-scanning
  • Positron Emission Tomografi Scan
  • Positron-emissionstomografi
  • PT
  • Positron emissionstomografi (procedure)

Given IV

Andre navne:
  • 1-OHP
  • Dakotin
  • Dacplat
  • Eloxatin
  • Ai Heng
  • Aiheng
  • Diaminocyclohexan Oxalatoplatin
  • JM-83
  • Oxalatoplatin
  • RP 54780
  • RP-54780
  • SR-96669
  • SR96669
  • Elplat
  • JM 83
  • JM83
  • RP54780
  • SR 96669

Given IV

Andre navne:
  • Folinsyre

Undergo bone scan

Andre navne:
  • Knoglescintigrafi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion
Eksperimentel: EAY191-A6 Arm II (RAS/RAF/MEK/ERK mutations)

Patients receive binimetinib PO, leucovorin IV, oxaliplatin IV, and fluorouracil IV on study. Patients undergo ECHO and MUGA during screening and on study, a CT with contrast, MRI, or an FDG-PET during screening, collection of blood during screening and on study, and a biopsy during screening. Patients may also undergo brain MRI or CT during screening and on study, bone scans on study, and biopsy on study if clinically indicated

Given IV

Andre navne:
  • 5-Fluracil
  • Fluracil
  • 5 Fluorouracil
  • 5 Fluorouracilum
  • 5 FU
  • 5-fluor-2,4(1H,3H)-pyrimidindion
  • 5-Fluorouracil
  • 5-Fu
  • 5FU
  • AccuSite
  • Carac
  • Fluor Uracil
  • Fluouracil
  • Flurablastin
  • Fluracedyl
  • Fluril
  • Fluroblastin
  • Ribofluor
  • Ro 2-9757
  • Ro-2-9757

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo ECHO

Andre navne:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navne:
  • Blood Pool Scan
  • Ligevægtsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-scanning
  • Synkroniseret Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid Ventrikulogram Scan
  • Gated Heart Pool Scan
  • RNV Scan

Undergo PET

Andre navne:
  • Medicinsk billeddannelse, Positron Emission Tomografi
  • KÆLEDYR
  • PET-scanning
  • Positron Emission Tomografi Scan
  • Positron-emissionstomografi
  • PT
  • Positron emissionstomografi (procedure)

Given PO

Andre navne:
  • ARRY-162
  • ARRY-438162
  • MEK162
  • Mektovi
  • ARRY 438162
  • ARRY 162
  • ARRY162
  • ARRY438162
  • MEK 162
  • MEK-162

Given IV

Andre navne:
  • 1-OHP
  • Dakotin
  • Dacplat
  • Eloxatin
  • Ai Heng
  • Aiheng
  • Diaminocyclohexan Oxalatoplatin
  • JM-83
  • Oxalatoplatin
  • RP 54780
  • RP-54780
  • SR-96669
  • SR96669
  • Elplat
  • JM 83
  • JM83
  • RP54780
  • SR 96669

Given IV

Andre navne:
  • Folinsyre

Undergo bone scan

Andre navne:
  • Knoglescintigrafi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion
Eksperimentel: EAY191-E4 (taxane therapy)

Patients receive nilotinib hydrochloride monohydrate PO BID on days 1-28 and paclitaxel IV over 1 hour on days 1, 8, and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo CT or MRI during screening or cycle 1 day 1, every 2 cycles for 1 year, every 3 cycles for patients on study for more than 1 year, and every 4 cycles for patients on study for more than 3 years and may also undergo CT or MRI during follow-up every 3 months for 2 years and then every 6 months for 1 year if clinically indicated. Patients also undergo collection of blood samples at baseline, cycle 2 day 1, and optionally at progression as well as tumor biopsy at baseline and optionally at progression.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Given PO

Andre navne:
  • AMN 107
  • Tasigna
  • AMN107
  • Nilotinib Monohydrochlorid Monohydrat
  • AMN-107

Given PO or IV

Andre navne:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat
Eksperimentel: EAY191-E5 Cohort I Arm A (sotorasib, panitumumab)

Patients receive sotorasib PO QD on days 1-28 and panitumumab IV on days 1 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo collection of blood samples, biopsy, and CT or MRI on study.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given IV

Andre navne:
  • ABX-EGF
  • ABX-EGF monoklonalt antistof
  • ABX-EGF, klon E7.6.3
  • MoAb ABX-EGF
  • Monoklonalt antistof ABX-EGF
  • Vectibix
  • E7.6.3
  • Humant IgG2K monoklonalt antistof
  • MoAb E7.6.3
  • Monoklonalt antistof E7.6.3

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Given PO

Andre navne:
  • AMG 510
  • Lumakras
  • AMG-510
  • AMG510
  • Lumykras
Aktiv komparator: EAY191-E5 Cohort I Arm B (sotorasib)

Patients receive sotorasib PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients with disease progression may cross-over to cohort II. Patients also undergo collection of blood samples, biopsy, and CT or MRI on study.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Given PO

Andre navne:
  • AMG 510
  • Lumakras
  • AMG-510
  • AMG510
  • Lumykras
Eksperimentel: EAY191-E5 Cohort II (sotorasib)

Patients receive combination therapy as in EAY191-E5 Arm A.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given IV

Andre navne:
  • ABX-EGF
  • ABX-EGF monoklonalt antistof
  • ABX-EGF, klon E7.6.3
  • MoAb ABX-EGF
  • Monoklonalt antistof ABX-EGF
  • Vectibix
  • E7.6.3
  • Humant IgG2K monoklonalt antistof
  • MoAb E7.6.3
  • Monoklonalt antistof E7.6.3

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Given PO

Andre navne:
  • AMG 510
  • Lumakras
  • AMG-510
  • AMG510
  • Lumykras
Eksperimentel: EAY191-N2 Cohort I (Arm I) (NF1 mutations)

Patients receive fulvestrant IM on day 1 and day 15 of cycle 1 and day 1 of subsequent cycles and binimetinib PO BID on days 15 to 28 of cycle 1 and day 1 through 28 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo a CT, MRI, or bone scan, ECHO or MUGA, and tumor biopsy, as well as possible blood sample collection during screening and on study.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo ECHO

Andre navne:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navne:
  • Blood Pool Scan
  • Ligevægtsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-scanning
  • Synkroniseret Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid Ventrikulogram Scan
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given PO

Andre navne:
  • ARRY-162
  • ARRY-438162
  • MEK162
  • Mektovi
  • ARRY 438162
  • ARRY 162
  • ARRY162
  • ARRY438162
  • MEK 162
  • MEK-162

Given IM

Andre navne:
  • Faslodex
  • Faslodex (ICI 182.780)
  • ICI 182.780
  • ICI 182780
  • ZD9238
  • ICI-182780
  • ICI182780
  • ZD 9238
  • ZD-9238

Undergo bone scan

Andre navne:
  • Knoglescintigrafi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion
Eksperimentel: EAY191-N2 Cohort I (Arm II) (NF1 mutations)

Patients receive fulvestrant IM on day 1 and day 15 of cycle 1 and day 1 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who progress on fulvestrant alone may migrate to cohort II if they meet the migration eligibility criteria. Patients not willing to migrate to cohort II will have further therapy at the investigator's discretion. Patients undergo a CT, MRI, or bone scan and tumor biopsy, as well as ECHO or MUGA and possible blood sample collection during screening and on study.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo ECHO

Andre navne:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navne:
  • Blood Pool Scan
  • Ligevægtsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-scanning
  • Synkroniseret Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid Ventrikulogram Scan
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given IM

Andre navne:
  • Faslodex
  • Faslodex (ICI 182.780)
  • ICI 182.780
  • ICI 182780
  • ZD9238
  • ICI-182780
  • ICI182780
  • ZD 9238
  • ZD-9238

Undergo bone scan

Andre navne:
  • Knoglescintigrafi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion
Eksperimentel: EAY191-N2 Cohort II (NF1 mutations)

Patients receive fulvestrant IM on day 1 of each cycle and binimetinib PO BID on days 15-28 of cycle 1 and day 1 through 28 of subsequent cycles. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo a CT, MRI, or bone scan, ECHO or MUGA and tumor biopsy, as well as possible blood sample collection during screening and on study.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo ECHO

Andre navne:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navne:
  • Blood Pool Scan
  • Ligevægtsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-scanning
  • Synkroniseret Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid Ventrikulogram Scan
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given PO

Andre navne:
  • ARRY-162
  • ARRY-438162
  • MEK162
  • Mektovi
  • ARRY 438162
  • ARRY 162
  • ARRY162
  • ARRY438162
  • MEK 162
  • MEK-162

Given IM

Andre navne:
  • Faslodex
  • Faslodex (ICI 182.780)
  • ICI 182.780
  • ICI 182780
  • ZD9238
  • ICI-182780
  • ICI182780
  • ZD 9238
  • ZD-9238

Undergo bone scan

Andre navne:
  • Knoglescintigrafi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion
Eksperimentel: EAY191-N4 Arm I (RAS pathway mutations)

Patients receive selumetinib PO BID and olaparib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo a tumor biopsy and blood collection during screening and on study, as well as ECHO or MUGA, and CT scans throughout the trial. Patients may undergo bone marrow aspiration or biopsy as clinically indicated.

Undergo bone marrow biopsy

Andre navne:
  • Biopsi af knoglemarv
  • Biopsi, knoglemarv

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo ECHO

Andre navne:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navne:
  • Blood Pool Scan
  • Ligevægtsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-scanning
  • Synkroniseret Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid Ventrikulogram Scan
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo bone marrow aspiration

Given PO

Andre navne:
  • Lynparza
  • AZD 2281
  • AZD-2281
  • AZD2281
  • KU-0059436
  • PARP-hæmmer AZD2281
  • KU0059436
  • Olanib
  • Olaparix
  • KU 0059436

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Undergo tumor mutational screening

Given PO

Andre navne:
  • AZD-6244 Hydrogensulfat
  • AZD6244 Hydrogensulfat
  • Koselugo
  • Selumetinibsulfat
Aktiv komparator: EAY191-N4 Arm II (RAS pathway mutations)

Patients receive selumetinib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who experience progression may elect to cross over to Arm I provided they have not had dose limiting toxicities to monotherapy selumetinib. Patients also undergo a tumor biopsy and blood collection during screening and on study, as well as ECHO or MUGA, and CT scans throughout the trial. Patients may undergo bone marrow aspiration or biopsy as clinically indicated.

Undergo bone marrow biopsy

Andre navne:
  • Biopsi af knoglemarv
  • Biopsi, knoglemarv

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo ECHO

Andre navne:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navne:
  • Blood Pool Scan
  • Ligevægtsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-scanning
  • Synkroniseret Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid Ventrikulogram Scan
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo bone marrow aspiration

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Undergo tumor mutational screening

Given PO

Andre navne:
  • AZD-6244 Hydrogensulfat
  • AZD6244 Hydrogensulfat
  • Koselugo
  • Selumetinibsulfat
Aktiv komparator: EAY191-N5 Arm I (neratinib maleate)

Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who experience progression may crossover to Arm II. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo ECHO

Andre navne:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navne:
  • Blood Pool Scan
  • Ligevægtsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-scanning
  • Synkroniseret Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid Ventrikulogram Scan
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Given PO

Andre navne:
  • Nerlynx
  • 2-butenamid, N-(4-((3-chlor-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E) -, (2Z)-2-butendioat (1:1)
  • HKI-272 maleat
  • NERATINIB MALEAT VANHYDRØST
Eksperimentel: EAY191-N5 Arm II (neratinib maleate,palbociclib)

Patients receive neratinib maleate PO QD on days 1-14 of cycle 0 in the absence of disease progression or unacceptable toxicity. Patients then receive neratinib maleate PO QD on days 1-28 and palbociclib PO QD on days 1-21 of each subsequent cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo ECHO or MUGA during screening and on study, and CT or MRI and collection of blood samples throughout the trial. Patients may also undergo tumor biopsy during screening and on study.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo ECHO

Andre navne:
  • Ekkokardiografi
  • EC

Undergo MUGA

Andre navne:
  • Blood Pool Scan
  • Ligevægtsradionuklidangiografi
  • Gated Blood Pool Imaging
  • MUGA
  • Radionuklid ventrikulografi
  • RNVG
  • SYMA-scanning
  • Synkroniseret Multigated Acquisition Scanning
  • MUGA Scan
  • Multi-Gated Acquisition Scan
  • Radionuklid Ventrikulogram Scan
  • Gated Heart Pool Scan
  • RNV Scan

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given PO

Andre navne:
  • Ibrance
  • 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-on
  • PD 0332991
  • PD 332991
  • PD 991
  • PD-0332991
  • PD0332991

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Given PO

Andre navne:
  • Nerlynx
  • 2-butenamid, N-(4-((3-chlor-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E) -, (2Z)-2-butendioat (1:1)
  • HKI-272 maleat
  • NERATINIB MALEAT VANHYDRØST
Eksperimentel: EAY191-S3 (activating AKT mutation)

Patients receive paclitaxel IV on days 1, 8, and 15 and ipatasertib PO on days 1-21 of each cycle. Treatment repeats every 28 days for up to 35 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo a CT or MRI and blood collection throughout the trial. Patients also undergo a tumor biopsy during screening and optionally during follow-up.

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo biopsy

Andre navne:
  • Bx
  • BIOPSY_TYPE
  • Biopsi

Given PO

Andre navne:
  • GDC-0068
  • RG7440
  • RG-7440
  • GDC 0068
  • GDC0068
  • RG 7440

Undergo blood collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Given PO or IV

Andre navne:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Accrual of patients to ComboMATCH treatment trials
Tidsramme: Up to 8 years

Will be estimated over time and considered in relationship to changes in treatment trial cohort status (activations, suspensions, terminations).

Up to 8 years
Assignment of patients to ComboMATCH treatment trials
Tidsramme: Up to 8 years

Will be estimated over time and considered in relationship to changes in treatment trial cohort status (activations, suspensions, terminations).

Up to 8 years
Enrollment rates to ComboMATCH treatment trials
Tidsramme: Up to 8 years

Will be estimated over time and considered in relationship to changes in treatment trial cohort status (activations, suspensions, terminations).

Up to 8 years

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Rate of positive outcomes within the treatment trial defined cohorts
Tidsramme: Up to 8 years

For each cohort in each treatment trial there is a defined primary efficacy endpoint (usually progression free survival [PFS] or overall response rate) and defined primary analysis for evaluating the primary endpoint. As cohorts are completed, whether they meet the criteria for a positive primary outcome will be determined. Positive treatment cohort outcome (on primary endpoint) will be analyzed as a binary random variable. The raw proportion of treatment cohorts with positive outcomes and an exact binomial confidence interval will be computed. If there are a sufficient number of treatment cohorts, logistic regression analysis will be performed examining the relationship of treatment cohort characteristics with successful outcomes. The goal is to achieve a rate of at least 30% with positive outcomes, both overall and in the subset of treatment trials based on in vivo models.

Up to 8 years

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Concordance between whole exome sequencing (WES) and results from the Designated Laboratory (DL)
Tidsramme: Up to 8 years

Whole exome and other sequencing will be performed on mandatory tissue biopsies or, if no biopsy tissue is available, on submitted formalin-fixed paraffin-embedded tissue. These assays will be done in a clinical laboratory (e.g., Clinical Laboratory Improvement Act-compliant); but results will not be returned to the clinical site. Results will be used to compare with the DL assay results. This comparison will be required to conduct an important secondary analysis of the primary endpoint in each cohort in each treatment trial, restricting to those cases that are concordant between WES and the result from the DL that was the basis for enrollment (integrated).

Up to 8 years

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: James M Ford, ECOG-ACRIN Cancer Research Group

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

7. april 2023

Primær færdiggørelse (Anslået)

1. juli 2030

Studieafslutning (Anslået)

1. juli 2030

Datoer for studieregistrering

Først indsendt

27. september 2022

Først indsendt, der opfyldte QC-kriterier

29. september 2022

Først opslået (Faktiske)

3. oktober 2022

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

12. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

11. november 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • NCI-2022-06842
  • U10CA180820 (U.S. NIH-bevilling/kontrakt)
  • NCI-2022-06842 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
  • EAY191 (Anden identifikator: CTEP)
  • EAY191 (Anden identifikator: ECOG-ACRIN Cancer Research Group)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ja

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .